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Abstract 
The textile industry sector has shown a growing interest in the functionalization of conventional 
fabrics to produce innovative products that enhance health, safety and ergonomics. This research 
is concerned with developing a functional fabric with durable antibacterial and fragrant 
properties by employing green chemistry materials and processes. This was achieved by 
microencapsulation of aroma compounds in biodegradable polymers by the complex 
coacervation method. Afterwards, the produced microcapsules were covalently attached to cotton 
fabrics by means of thermofixation grafting process using a polycarboxylic acid. The effects of 
different processing parameters, including the type and amount of the emulsifier, the type and 
amount of the hardening agent, and the wall to core ratio, on the morphology, size, dispersion, 
encapsulation efficiencies (EE%) of the produced microcapsules were examined. The release 
profiles of the active agents were investigated. The impact of different grafting conditions on the 
microcapsules adhesion was inspected. Scanning electron microscopy (SEM) and Fourier 
Transform Infrared (FTIR) spectroscopy confirmed the adhesion of the produced microcapsules 
on the cotton fabrics. The antibacterial assays of both the produced microcapsules and the 
functionalized fabrics demonstrated that they exhibited a sustained antibacterial activity. 
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W/O                               water-in-oil 
W/O/W                          water-in-oil-in-water 
WPI                               whey protein isolate 
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Chapter 1: Introduction 
1.1. Relevance and motivation 
The increase in the market competitiveness along with the diversity of consumers’ demands has 
created a challenging environment in the textile industry sector. This subsequently led to the 
production of innovative textile products with new properties that enhance ergonomics, health 
and safety.
1
 Functional textiles are one of those novel products in the textile area. They are 
obtained by either incorporating active ingredients to conventional fabrics, such as cotton, wool, 
silk or polyester, or by manufacturing new materials (e.g., nanofibers and nanocomposites).
2,3
 
Innovative technologies in textiles have succeeded in offering a wide variety of fabrics with 
unprecedented functions. The most common applications of functional textiles include phase 
change materials, insect repellents, antimicrobials, fragrances, dyes and colorants, skin softeners 
and moisturizers, some medicines, and flame retardants.
2,4-8
 
 Enhancing the durability and prolonging the lifetime of functional textiles have been always one 
of the most challenging missions for the manufacturers of these types of textiles. This is due to 
the fact that these textiles are non-disposable and need to be washed after use. 
Microencapsulation techniques have been known to provide textiles with long-lasting properties 
and added value.
9,10
 This process involves the coating of the active ingredient with one or more 
polymeric materials to form microcapsules whose size range between 1µm and 1000µm. These 
microcapsules when later fixed onto the fabrics, they create a product with new properties and 
added value. In fact, each microcapsule acts as a minute reservoir for the active ingredient which 
would be liberated under specific conditions, such as pH, mechanical factors, temperature or 
diffusion.
11
 Therefore, the process of microencapsulation allows the controlled release of the 
active substances and their protection against the surrounding environmental conditions, such as 
heat, oxygen, and light.
1,2
 This process thus, remarkably increases the durability and long 
lastingness of the effect of the functional ingredient incorporated onto these textiles. 
Nowadays, researchers and manufacturers are increasingly interested in green chemistry 
protocols, taking into account the growing public concern and awareness of the importance of 
the utilization and application of safe and eco-friendly materials and processes. However, the 
majority of the commercially available microcapsules that are intended for textile applications 
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are made of melamine-formaldehyde, urea-formaldehyde or phenol-formaldehyde resins.
12,13
 
Regardless of the fact that these polymers are used because of their good thermal stabilities and 
their ability to be modified according to the desired release profiles, they represent a serious 
threat for the environment and human health. This is due to their being non-recyclable 
thermosetting polymers, and also due to the carcinogenicity and toxicity of formaldehyde.
14,15
 
Thus, the replacement of such resins with safe and environmentally benign materials has become 
extremely important.
16
 Biocompatible and biodegradable polymers, such as alginate, gum 
Arabic, gelatin, chitosan, and cyclodextrins, have recently become promising alternatives for the 
previously mentioned toxic polymers; as they are known to be eco-friendly, abundant, and safe 
to human health.
17
  
Fabrics of natural origins, such as cotton are known to be more susceptible to colonization by 
invasive microbes than synthetic ones.
16
 This is due to their high hydrophilic and porous 
composition that tends to retain humidity, nutrients, and oxygen, which is indeed considered as 
an ideal environment for the growth of high number of microorganisms.
16,18
 Consequently, these 
microorganisms result in unpleasant odors, transmission of diseases and allergic responses in 
some individuals. Additionally, they cause the deterioration of fabrics in terms of color 
degradation, loss of elasticity and tensile strength, and interference with the dyeing and printing 
processes.
16,19
 Hence, it is crucial to combat these undesired effects through imparting 
antimicrobial additives to textiles.  
1.2.  Statement of purpose 
This study aims to confer antimicrobial and fragrant properties to cotton fabrics by means of 
microencapsulation, depending on green and eco-friendly materials, and thus contribute to the 
ongoing advancements in the fields of both microencapsulation and functional textiles. 
The main investigations that were conducted in this thesis are as follows: 
The preparation of the microcapsules and formulation optimization was achieved by means of 
the complex coacervation microencapsulation method; using chitosan and gum Arabic as shell 
materials. Vanillin and limonene were incorporated independently as core (active) materials. The 
influence of using different process parameters (e.g., type and amount of emulsifier and type of 
hardening agent) was studied to optimize the final formulation of the microcapsules. This was 
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followed by the characterization of the prepared microcapsules through the analysis of the 
morphology, particle size distribution and encapsulation efficiency of the prepared 
microcapsules. The release of active agents was also investigated through release profiles of both 
limonene and vanillin microcapsules employing GC-FID. The grafting of the microcapsules to 
cotton fabrics was done by the pad-dry-cure method using citric acid as a cross-linker. SEM was 
used to examine the treated fabrics before and after washing and FTIR spectroscopy was used to 
confirm the covalent attachment of the produced microcapsules to the cotton fabrics. Finally, 
antimicrobial assays were conducted to examine the antibacterial activities of the produced 
vanillin and limonene microcapsules. These were evaluated using the Agar Diffusion Method, 
whereas the antibacterial activity of the treated fabrics was assessed by the Standard Test Method 
under Dynamic Contact Conditions (American Society for Testing & Materials, ASTM Standard 
E 2149-01).  
To the best of our knowledge, no reports previously investigated the microencapsulation of 
vanillin powder by the complex coacervation microencapsulation technique. Furthermore, 
limonene encapsulation using chitosan and gum Arabic as a complex coacervation pair was not 
previously reported in the literature. 
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Chapter 2:  State of the Art 
2.1. Microencapsulation: Definition and Purpose 
Microencapsulation involves the entrapment of solid, liquid or gaseous materials in small 
particles that release their contents at a controlled rate over a prolonged period of time and under 
certain conditions.
1,2
 These particles are called microcapsules. The word “encapsulate” is derived 
from the Latin words; “en” which means in and “capsula” which means a small box. Thus, the 
overall meaning of to encapsulate is to place something in a box.
3
 Microcapsules have a diameter 
of 1-1000 µm.
4-6
 They are made up of a core (inner part) which contains the active material, and 
a wall material (outer part) that surrounds the core and creates a physical barrier around it.
2
 The 
core is also called the nucleus, payload phase, fill or internal phase; whereas the wall material is 
sometimes called the shell, encapsulant, carrier or external phase.
4,7
 The core material can be in 
the form of solid, liquid, or gas. The morphological structure of microcapsules depends on 
different parameters, e.g., the type of the shell material, its rigidity, and the preparation method 
used. The shape of the microcapsule may range from being spherical, irregular, with one core or 
multicores, with single coating or coatings that consist of more than one layer. 
Microencapsulation protects the active agent from different adverse conditions in the 
surrounding environment, such as humidity, air, heat, light and exposure to changes in pH. 
Additionally, it guards against the rapid evaporation of highly volatile active agents and helps in 
controlling the rate of their release.
6
 
2.2 Microencapsulation Techniques 
There are different techniques used for the preparation of microcapsules. They can be classified 
into three main categories being the chemical methods, the physico-chemical methods, and the 
physico-mechanical methods. 
2.2.1. Microencapsulation by Chemical methods 
 In situ polymerization  
In this method the wall material of the microcapsule is chemically produced due to the 
polymerization of monomers added to an emulsion that is formed of a dispersed core material 
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and a continuous phase. Subsequently, polymerization starts to occur at the interface between the 
continuous phase and the immiscible core material, on the continuous phase side. In the 
beginning of the process, a prepolymer of low molecular weight is formed then it grows with 
time and deposits on the interface between the continuous phase and core material creating a 
solid shell.
8
 In this method no reagents are added to the core material and the polymerization 
occurs exclusively in the continuous phase.
9
 
 Interfacial polymerization 
In interfacial polymerization, the shell of the capsule is formed on the surface of a core droplet as 
a result of the polymerization of reactive monomers. Two sets of monomers that are able to react 
with each other are used. This method basically involves the formation of an emulsion of two 
immiscible phases, where one of the monomers is solubilized in the core material and a co-
monomer is added to the continuous phase. The reaction conditions are then set to promote the 
polymerization and the wall formation at the interface.
10
 
The most commonly used monomers are the multifunctional isocyanates and acid chlorides.
8
 The 
reaction of isocyanate with an amine results in the formation of a polyurea shell, whereas the 
reaction of acid chloride with an amine results in the formation of a polyamide or a polynylon 
microcapsule shell. Polyurethane shell materials are obtained by the reaction of isocyanate with a 
hydroxyl containing monomer. Both liquid and solid core materials can be encapsulated by this 
method. 
8,9
 
2.2.2. Microencapsulation by Physico-mechanical methods  
 Spray drying 
Spray drying involves the atomization of a solution or suspension of the active agent and the 
coating material into a heated drying gas which causes the water to evaporate rapidly, leaving 
dried microcapsules. The microcapsules are then obtained by continuous discharge from a 
collecting chamber in the spray dryer.
5,8
 The initial temperature of the air is usually 150-220°C 
which allows evaporation to occur quickly, then it decreases to be within the typical range of 50-
80°C.
11
 The spray drying technique is suitable for the encapsulation of labile and thermally 
sensitive substances due to the short exposure time to heat, which typically does not exceed few 
seconds.
11,12
 This method produces small microcapsules in the form of very fine powder (10-50 
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µm) or large particles that are 2-3 mm in diameter.
11
 Spray drying is considered the most popular 
microencapsulation technique used in food industry.
13
 It has the advantage of being economic, 
rapid and efficient. However, this method has the disadvantage of requiring a coating agent that 
should be soluble in water to a certain extent. The use of shell materials with low water solubility 
(e.g., sodium caseinate, whey protein, carboxymethyl cellulose, and guar gum) makes the 
process expensive due to the need of increasing the amount of water used, and thus requiring 
more time for its evaporation.
11
 
 Spray chilling 
Spray chilling involves the loading of the core material into a warm bath of the wall material 
followed by spraying through a heated nozzle allowing the shell to solidify and form the 
microcapsules. Spray chilling is carried out by equipment similar to the one used in spray drying 
but the air used is not heated.
5
 
 Solvent evaporation/extraction 
Microencapsulation by solvent evaporation is carried out through four main steps: (1) dissolution 
of the active core in an organic solvent that contains the polymeric shell material; (2) 
emulsification of the organic (dispersed) phase in an aqueous (continuous) phase; (3) extraction 
of the solvent from the dispersed phase by the continuous phase, and evaporation of the solvent 
from the organic phase by heating; which causes the coating material to shrink around and 
encapsulate the core agent; (4) recovery and harvesting of the formed microcapsules.
8,14,15
 The 
solvent evaporation technique is most commonly applied in the pharmaceutical industry because 
it provides a controlled release profile of drugs.
15
 
 Air suspension coating 
The air suspension technique involves suspending solid core particles in a chamber supported 
with an upward flowing air stream, and spraying of the coating material onto the suspended 
particles.
8,12
 The air stream carries the particles in a repetitive circulating pattern to the coating 
zone in the chamber, where a polymeric coating material is being sprayed to the moving 
particles. The number of the cycles applied depends on the desired thickness of the wall 
material.
9,12
 The coating material used can be in the form of aqueous or solvent solution, 
emulsion, suspension or hot melt. The supporting air stream aids in the solidification of the 
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coating and drying of the produced microcapsules.
12
 This technique is used to encapsulate solid 
cores, such as granules, crystals and powders. This technique however cannot be used to coat 
liquid droplets unless they are first absorbed on a porous solid.
9
   
 Pan coating 
The pan coating technique is one of the oldest methods used in the pharmaceutical industry to 
produce coated particles and tablets. The solid cores are initially tumbled in a rotating pan-like 
container in which the coating material is slowly applied in the form of solution or atomized 
spray. The solvent is then removed through passing warm air over the produced coated particles,  
or by means of drying oven.
12
 The method is also used in microencapsulation to produce 
microparticles of size greater than 600 µm, usually for controlled-release purposes.
16,17
  
 Centrifugal extrusion 
The centrifugal extrusion technique is used to encapsulate liquid cores. It involves the usage of a 
rotating extrusion head with concentric nozzles. The core material is pumped through a central 
tube and the wall material in a liquid form is pumped through a surrounding circular space.
9,12
 
Consequently, the coating material comes out at the end of the nozzle forming a membrane that 
surrounds the core material which flows out of the nozzle simultaneously causing the extrusion 
of a liquid jet (Figure 2.1). This jet later breaks into droplets of the core material coated with the 
wall material. Hardening of the droplets takes place later by allowing their passage into a heat 
exchanger.  
 
Figure 2.1 Schematic diagram of a centrifugal extrusion device with two-fluid nozzle. Adapted 
from Ref. 9. 
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The centrifugal extrusion method is known to form microcapsules of 400-2000 µm in size.
9
 
Centrifugal extrusion can be applied for large scale production; since 22.5 kg of microcapsules 
can be formed per hour using special nozzles, additionally, multiple-nozzle systems can be used, 
e.g., heads of 16 nozzles are already available.
12
 
2.2.3. Microencapsulation by Physico-chemical methods 
 Supercritical fluids assisted microencapsulation 
This technique is considered environmentally friendly where supercritical fluids are used as 
green solvents. Supercritical fluids are highly compressed gases, such as CO2, N2O, and alkanes 
(C2 to C4), and are known to possess the properties of both gases and liquids in terms of viscosity 
and diffusivity. Supercritical fluids are known as fluids kept at conditions above their critical 
point. They have almost zero surface tension.
18
 Supercritical fluid technology is suitable for shell 
materials that dissolve in supercritical fluids, and polymers that do not dissolve in them. In 
practice, the process involves maintaining the core material and the shell material at high 
pressure, followed by their release at atmospheric pressure through a nozzle. The quick drop in 
pressure causes the desolvation of the shell and its deposition around the core agent.
19
 
Microencapsulation using supercritical fluids provides the advantage of their high solvating 
power, and hence the solubilization of the coating and core materials is fast and is done in the 
absence of water.
20
  
 Coacervation 
Coacervation is based on the separation of an initial homogenous polymer solution into two 
phases: a polymer-rich phase (coacervate) and the other is almost polymer free and called the 
equilibrium solution. The origin of the word coacervation is derived from the Latin word 
“acervus” which means heap.8 Microencapsulation by coacervation provides controlled release 
of the active agent and high encapsulation efficiency.
20
 Microencapsulation by coacervation is 
divided into simple and complex coacervation. The former is carried out using a single polymer 
as the shell material, while the latter occurs by the interaction of two oppositely charged 
polymers.
21
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i) Simple Coacervation 
Simple coacervation is induced by changing the pH or temperature, or the addition of inorganic 
salts (e.g., sodium sulfate) in order to precipitate the initial solubilized wall material.
20,22
 Phase 
separation and formation of coacervate of the polymeric wall material is followed by its 
adsorption around the core material.
23
 
ii) Complex Coacervation 
The complex coacervation technique is described in depth here since it is the microencapsulation 
method used in this study.  It is one of the important microencapsulation techniques due to its 
high loading capacity, mild reaction conditions and controlled release possibilities.
24,25
 It is also 
considered a green method that does not require the use of organic solvents.
26
 Complex 
coacervation phenomenon was first reported in 1911 and was then studied more 
comprehensively in the 40s in the light of the polymer system gelatin/gum Arabic. Nevertheless, 
its use and application in the food industry only started in the 50s.
27
 More detailed and extensive 
studies on the method have emerged during the last two decades. Figure 2.2 shows the number of 
articles related to microencapsulation by coacervation in the period from 1995 to 2016. Complex 
coacervation is defined as a fluid-fluid phase separation process that occurs as a result of 
electrostatic attraction between two oppositely charged polymers. It may also involve hydrogen 
bonding and hydrophobic interactions between the oppositely charged polymers.
7
 
 
Figure 2.2 Number of scientific documents on microencapsulation/complex coacervation 
published since 1995. (Obtained from Scopus database, February 2016; Search field: 
microencapsulation complex coacervation; “in article title, abstract, and keywords”).  
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Complex coacervation proceeds by mixing two polymer solutions with opposite charges, which 
leads to their phase separation from the initial solution and subsequently their deposition around 
an active core (Figure 2.3). The phase separation takes place by changing the pH or temperature, 
or the addition of an electrolyte solution which results in the formation of coacervates that tend 
to precipitate at the oil/water interface as a result of repulsion with the solvent.
28,29
 Consequently, 
two phases are obtained; one is rich in the coacervate and is called the polymer-rich phase and 
the other contains the solvent and is called solvent-rich phase.
7
  
Figure 2.3 Schematic representation of complex coacervation method showing the formation of 
coacervates between two oppositely charged polymers and their deposition at the core interface 
creating the shell. Adapted from Ref. 29.  
The classical and most extensively studied complex coacervation model is the gum Arabic 
(negatively charged polyelectrolyte) and gelatin (positively charged polyelectrolyte).  This 
system has received considerable attention in industrial applications. It has been used in the 
manufacture of carbonless paper, fragrance strips and samplers, and flavor incorporation.
30
 
However, gelatin is not always preferred due to its high viscosity and the new regulations that 
restrict the use of some animal-derived proteins in some countries.
24
 Hence, other complex 
coacervation pairs that exhibit new properties have emerged recently. These new systems are 
based on proteins other than gelatin, and polysaccharides. The proteins are either of animal 
origin, such as silk fibroin, albumin, and whey proteins, or of plant origin such as, soy and pea 
proteins.
7
 The polysaccharides include gum Arabic, chitosan, alginate, sodium carboxymethyl 
cellulose, and carrageenan.
7,26,31
 Complex coacervation is used mainly for the encapsulation of 
essential oils, some drugs, vitamins, nutraceuticals (e.g.,omega-3) and different various food 
ingredients.
7
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The complex coacervation method typically involves the five following steps: 
7,27
 
1. Dissolution and hydration of polymers to obtain aqueous solutions of the two polymers, 
(either a protein and a polysaccharide or two oppositely charged polysaccharides) at a 
temperature and pH above their gelling point.    
2. Emulsification step where creating an emulsion of the hydrophobic core material in the 
aqueous phase is accomplished. The emulsion is typically stabilized by a surfactant 
and/or one of the polymers. 
3. Coacervation and shell formation due to changing the reaction conditions, such as 
lowering the pH, the two polymers would interact by electrostatic attraction and form a 
complex that would eventually deposit on the oily droplets of the core. The pH is one of 
the important parameters in this step as it directly affects the degree of ionization of the 
functional groups of the polymers.  
4. Hardening by means of adding a cross-linker to harden the shell. 
5. Separation of the microcapsules which are isolated from the reaction mixture by either 
decantation or centrifugation. The microcapsules are usually dried to get a sample in a 
powder form.  
In spite of the advantages that the complex coacervation technique offers, there are two main 
limitations for this method. Firstly, the method is mainly suitable for the encapsulation of 
hydrophobic core materials and is not ideal for encapsulating hydrophilic cores. However, the 
introduction of some changes to the conventional coacervation method enables the incorporation 
of hydrophilic cores, such as including a double emulsion step which comprises the formation of 
a primary w/o emulsion in the beginning of the process before coacervation, followed by a 
double w/o/w emulsion.
32-34
 Although the double emulsion method is reported to be effective in 
encapsulating hydrophilic substances, it adds to the cost of the process.
7
 The second 
disadvantage of this method is that the majority of the articles in the literature cited the use of 
toxic aldehydes (e.g., formaldehyde, glyoxal and glutaraldehyde) as cross-linkers for the wall 
polymers, which is not legislated in some countries.
35
 This problem could be solved by using 
non-toxic hardening agents, such as transglutaminase enzyme
36
, genipin
37
 or tripolyphosphate.
38
 
In this study, two hardening agents were used; the polyanion tripolyphosphate and tannic acid, 
which are both reported to be non-toxic and environmentally friendly.
38,39
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2.3 Microcapsules wall material: Biodegradable polymers 
There is a wide variety of natural and synthetic shell materials that are used in 
microencapsulation. The choice of the appropriate coating material depends on the final product 
objective and requirements; as it will determine the final properties of the resulting 
microcapsules. The product requirements may include a specific controlled release profile, 
reduction of volatility, adding value and functionalization or stabilization of an active agent. 
Moreover, the resulting encapsulation efficiency should be taken into consideration. The ideal 
polymer should be non-toxic, insoluble and non-reactive with the material intended to be 
encapsulated and should readily deposit on its surface to form a cohesive film of a suitable 
thickness around it.
17
 The selection criteria may also be influenced by economic factors. The use 
of natural biodegradable polymers has been recently of high interest; mainly because they are 
naturally abundant, eco-friendly and biocompatible. Biodegradable polymers, both natural and 
the synthetic, are known to be eco-friendly due to their capability to cleave into biocompatible 
products through chemical or enzymatic hydrolysis.
40
 Biodegradable polymers are also able to 
release the active agent in a controlled pattern. Examples of synthetic biodegradable polymers 
that are used in drug microencapsulation include polyesters, polyorthoesters, polyphosphazenes 
and polyanhydrides, while natural biodegradable polymers are either based on proteins (such as 
gelatin, albumin, and collagen) or polysaccharides (such as, chitosan, hyaluronic acid, gum 
Arabic, alginate, maltodextrin, starch, ethyl cellulose and carrageenan).
11,40
 Owing to the fact 
that one wall material may not possess all the desired requirements for a certain application, a 
combination of different encapsulating materials is sometimes used.
11
 
2.3.1. Chitosan 
Chitosan has recently acquired great attention in different areas due to its interesting properties, 
such as being non-toxic, biodegradable, non-allergic, mucoadhesive, excellent film forming 
ability and being a potent antimicrobial agent.
41,42
 It has been widely used in several industrial 
applications, such as food engineering and packaging, wastewater treatment, cosmetics, textile 
coating, pharmaceuticals, biomedicine and tissue engineering. Chitosan is a linear 
polysaccharide made of β- (1→4) linked monosaccharide units of β-(1,4)-2- amino-2-deoxy-D-
glucose (Figure 2.4). It is a biodegradable polymer derived from chitin, which is the second most 
 15 
 
abundant polysaccharide in nature.
11,40
 Chitin occurs mainly in the skeletons of crustaceans, 
insects and in the cell wall of some fungi. The acetamide (N-acetyl) group in chitin is chemically 
converted by alkaline treatment into an amino group to obtain chitosan. The degree of 
deacetylation “DDA” is a term that shows the amount of 2-amino-2-deoxy-D-glucose (D-
glucosamine) units in a molecule of chitosan.
43
 The commercially available chitosan is known to 
have a DDA of 66% to 98%. At alkaline and neutral pH, chitosan has free amino groups and 
therefore, it is insoluble in water. At acidic conditions, the amino groups become protonated, and 
hence chitosan becomes soluble.
44
 
Figure 2.4 Chemical structure of (a) chitin and (b) chitosan. Adapted from Ref. 44. 
The DDA of chitosan affects its solubility; since it reflects the amount and distribution of the free 
amino groups in relation to the remaining N-acetyl groups.
42,43
 The DDA also influences the 
complexation ability of chitosan since a higher DDA results in a higher charge density and 
greater complex formation capability.
43
 Additionally, the biodegradability of chitosan is affected 
by its DDA.
11
 The biodegradability of chitosan is of high importance for the release of the 
encapsulated material. It has been reported that the variations in the DDA of chitosan affects the 
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release profile of the drug isoniazid, and that the higher the DDA of the chitosan used, the faster 
the reported rate of release.
45
 
The antibacterial activity of chitosan pertains to the positive charge on its protonated amino 
groups.
41,46
 The DDA and the pH define the extent of the charge density of chitosan, and hence, 
its antibacterial activity. The majority of amino groups on C-2 of chitosan acquire cationic 
charge at low pH (lower than its pKa ~ 6). This protonation enhances the interaction between 
chitosan and the anionic charges of lipopolysaccharides on the surface of the Gram negative 
bacteria, and with the anionic peptidoglycans in Gram positive bacteria.
47
 Consequently, these 
interactions lead to changes and disruption in the permeability of the bacterial cell and leakage of 
the vital intracellular substances; which affects the functions and bioactive processes of the 
microorganism and finally its death.
48,49
 
Cross-linking of chitosan involves the introduction of intermolecular bridges between the 
polysaccharide macromolecules by using specific reagents known as cross-linkers.
50
 Cross-
linking reactions are known to decrease the mobility of the polymer segment and results in the 
interconnection between the polymer chains through new linkages.
11,50
  It has been reported that 
the cross-linked chitosan microcapsules are more efficient for the controlled release applications 
as compared with those that are not cross-linked.
50
 The cross-linking reaction is affected by the 
size and kind of the cross-linking agent used. Generally, the smaller the size of the cross-linker, 
the faster the reaction; as its diffusion between the function groups of the polymer becomes 
easier.
51
 According to the interaction of the cross-linker with chitosan, the cross-linking reaction 
can be classified into chemical or physical. The chemical cross-linking results in networks made 
by permanent covalent bonding between the chitosan chains.  The amino and the hydroxyl 
groups of chitosan are the cross-linking sites that form ester linkages, amide linkages, and 
sometimes Schiff bases. The chemical cross-linking reaction depends mainly on the 
concentration of the cross-linkers, as well as the exposure time. Examples of well-known 
chemical cross-linkers are genipin, glutaraldehyde, vanillin which forms a Schiff base, and 
epichlorohydrin.
50
 The physical cross-linking depends on electrostatic interactions between the 
chitosan and the counterions. The physical cross-linkers are polyanionic compounds and they 
include phosphoric acid salts (e.g., tripolyphosphate), citric acid, and sulfate.
11,50,51
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2.3.2. Gum Arabic 
Gum Arabic (GA) is the dried exudate of Acacia senegal and Acacia seyal trees, Family 
Leguminosae.
52
 Sudan, Nigeria, Chad, Ethiopia and Senegal are the main producers. It is 
harvested as dried sap (Figure 2.5). The use of GA dates back to the time of ancient Egyptians; 
as they used it as a binder in paints, inks, cosmetics and in embalming mummies.
53
 It is now 
widely used in food, pharmaceutical and cosmetic industries for its notable stabilizing, binding, 
thickening and emulsifying properties. It is also used in the textile industry to thicken the 
printing pastes which are used in the coloration of cellulose fabrics.
53
 GA is also reported to have 
antimicrobial effects against some fungal pathogens, such as Candida albicans and Cryptococcus 
neoformans.
52
 
GA is a branched heteropolysaccharide polymer that exists as a mixture of calcium, potassium 
and magnesium salts. 
53
 The main fraction of GA (88-90%) is composed of two chains: the main 
chain consists of 1,3-linked β-D-galactopyranosyl units, while the side chains consist of two to 
five units of 1,3-linked β-D-galactopyranosyl units joined by 1,6-linkages. Both chains contain 
α-L-arabinofuranosyl, α-L-rhamnopyranosyl, β-D-glucuronopyranosyl and 4-O-methyl-β-D-
glucuronopyranosyl units. 
52-54
 The secondary fractions (10%) is composed of both complex 
arabinogalactan-protein (AGP) and glycoprotein (GP).
55
 
 
Figure 2.5 Gum Arabic exudate on Acacia tree. Adapted from Ref. 52.  
GA is widely used in microencapsulation due to its low viscosity, excellent emulsification 
properties, high solubility in water, film-forming capability and high ability to retain and protect 
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volatile compounds.
56
 It is believed that the emulsifying ability of gum Arabic is related to the 
AGP complex in its structure; since it is an amphiphilic protein component that can deposit on 
the surface of the oil droplets, while the carbohydrate fraction remains directed to the aqueous 
phase preventing the coalescence of the oil phase droplets.
55
  
2.4. Microcapsules core material 
2.4.1. Vanillin  
The core material is the substance present in the inner part of the microcapsule over which the 
shell material is applied. Vanillin (Figure 2.6) is one of the most widely used flavoring agents 
and it is generally regarded as safe (GRAS). It is a plant metabolite obtained from the beans or 
pods of the tropical orchid Vanilla planifolia. It is native to Mexico and Central America, and is 
now cultivated in Madagascar, Indonesia, Uganda and Guinea. Madagascar is the largest 
producer followed by Indonesia 
57,58
 Due to the high cost of the process of growing and 
harvesting the vanilla orchid, most of the vanillin used in pharmaceuticals, perfumery, food 
products, and cosmetics is chemically synthesized. In fact, the naturally used vanillin makes up 
only less than 1% of the total vanillin produced worldwide.
59
  
 
Figure 2.6 Structure of vanillin (4-hydroxy-3-methoxybenzaldehyde).  
The volatile nature of vanillin and its limited solubility in water make its use in different 
applications problematic.
60,61
 Moreover, the presence of a phenolic and an aldehydic group in its 
structure makes it highly susceptible to oxidation and thermally unstable.
62
 Therefore, its 
protection by encapsulation is worth investigating to increase its stability and functionality. 
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Table 2.1 represents examples of the different methods that have been reported on vanillin 
microencapsulation. 
Vanillin has been reported to possess several bioactive effects, such as antioxidant, 
antimicrobial, anticarcinogenic and antimutagenic properties.
57
 Vanillin is incorporated in a lot 
of food preparations not only for being a sweet flavoring agent, but also due to its antimicrobial 
property making it into a “phytopreservative” or a “green preservative”,63 which satisfies the 
needs of consumers who look for natural additives rather than chemical ones. It has been 
reported to have a potent antimicrobial activity against gram negative and gram positive 
bacteria,
64,65
 yeasts and molds. Vanillin antibacterial activity has been recognized against 
Staphylococcus aureus, Staphylococcus epidermidis, Enterobacter aerogenes, Escherichia coli, 
Listeria monocytogenes and Yersinia enterocolitica which are known to cause skin diseases and 
gastrointestinal tract problems.
62,66
 The antibacterial activity of vanillin depends on its 
concentration, exposure time and the target microorganism.
46
 It has also been reported that the 
antifungal activity of vanillin is attributed to its aldehyde moiety and the position of the side 
groups on its benzene ring.
67
   
Recent studies also demonstrated the ability of vanillin to protect against chronic depression and 
induce relaxation through olfaction and oral adminstration.
68,69
 It is claimed that the 
antidepressant effect of vanillin is connected to its adrenergic agonistic activity.
69
 Furthermore, it 
was found that the exposure to a familiar vanillin scent decreases neonates’ crying that 
accompany pain attacks and alleviates the concomitant symptoms, such as energy depletion and 
increased risk of hypoxemia.
70
 
To the best of our knowledge, the microencapsulation of vanillin using complex coacervation 
method has not been previously reported. 
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Table 2.1 Examples of different methods of vanillin microencapsulation and their area of 
application. 
Method Wall material Application  Reference 
Spray Drying  Chitosan Textiles 
60
 
Phase Inversion by  Polysulfone Textiles 
64,71
 
immersion precipitation  
  
 
Spray-freeze drying β-CD Food preparations 72 
 
WPI 
 
 
 
β-CD + WPI 
 
 
Spray Drying  Sodium alginate Food preparations 
73
 
 
Methyl β-CD 
 
 
 
Inulin 
 
 
 
Hydroxypropylmethyl cellulose 
  
Spray Drying  Soy protein isolate-maltodextrin Food preparations 
13
 
Emulsion stabilization Carnauba wax Food preparations 
74
 
 
Maltodextrin 
 
 
 
β-CD 
 
 
 
Gum Arabic 
 
 
Freeze-drying β-CD Food preparations 75 
Multilayer emulsion  Soy protein isolate Food preparations 
76
 
and spray drying Modified starch 
 
 
  Chitosan    
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2.4.2. Limonene 
D-limonene (Figure 2.7) is one of the most abundant terpenes that occur naturally. It represents 
the main constituent in the essential oils of citrus fruits, such as orange, lemon, lime and 
grapefruit. Its optical isomer is L-limonene; it has a turpentine odor and is mainly found in the 
volatile oils of pine and oak trees.
77
 D-limonene is listed as a GRAS compound in the Code of 
Federal Regulations, and is used widely in the food and cosmetic industries as an important 
flavor and fragrance.
78
 It is clinically used to dissolve gallstones and treat heartburns.
78,79
 It has 
been also reported to have an anti-tumor and chemo-preventive activity against mammary, colon 
and lung cancers.
80
 D-limonene has also been reported to lower the risk of skin carcinoma.
81
 
 
 
 
Figure 2.7 Structure of d-limonene (4-isopropenyl-1-methylcyclohexene). 
D-limonene has a potent antimicrobial activity against several bacteria such as Salmonella spp.,
82
 
E. coli,
83
 Staphylococcus aureus and Pseudomonas aeruginosa.
84
 Antifungal properties of d-
limonene have been also reported.
85
 The chemical structure of the essential oil denotes its 
antibacterial behavior. Limonene has more potent antibacterial activity than p-cymene; because 
the alkenyl group of the former is oxidized upon exposure to air and forms ions that disturbs cell 
wall, which is not the case of the alkyl group of the latter.
86
 Limonene is capable of penetrating 
the lipid barrier in the bacterial cell wall. This results in the denaturation of the protein 
components of the bacterial cell membrane, causing the leakage of the cytoplasmic constituents 
which in turn disrupts the energy status and eventually leads to cell death.
83,86
  
Table 2.2 shows different methods that have been reported on limonene microencapsulation and 
the wall materials used in each method. Much has been published about the encapsulation of 
limonene with various methods including complex coacervation; yet most of the literature 
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available on the microencapsulation by complex coacervation refers to the use of pairs of wall 
materials other than the chitosan and gum Arabic together. Leclercq et al.
87
 compared limonene 
protection against oxidation to limonene oxide by both complex coacervation and spray drying 
methods. They reported that microencapsulation by complex coacervation has fully protected 
limonene against oxidation to limonene oxide during 25 days of storage, whereas high amount of 
limonene oxide was produced over the same duration when spray drying technique was used.
87
 
Table 2.2 Examples of different methods used for limonene microencapsulation and their area of 
application. 
Method Wall material Application Reference 
Complex coacervation Chitosan/gelatin Textiles 
88
 
Complex coacervation Gelatin/carboxymethyl cellulose Footwear 
89
 
In situ polymerization Melamine-formaldehyde resin Footwear 
89
 
Complex coacervation Gelatin/gum Arabic Flavors 
87
 
Spray drying Gelatin/gum Arabic Flavors 
87
 
Interfacial polymerization Polyurethane-urea Textiles 
90
 
Simple coacervation Chitosan Non-woven Fabrics 
91
 
Spray drying Gum Arabic/maltodextrin Flavors 
92
 
Ultra-high pressure Gelatin/sucrose/gum Arabic Flavors 
93
 
homogenization and 
  
 
freeze drying 
  
 
Molecular inclusion β-CD Flavors 94 
Simple coacervation Gum Arabic Textiles 
95
 
                       
2.5. Release Mechanisms 
Microencapsulation allows effective shielding and protection of the active agent from 
degradation by the surrounding environment. At the same time, it offers controlled release of the 
active agent over long periods. The rate of the controlled release depends on the nature of the 
coating material, its thickness and porosity.
17,96
 Moreover, it depends on the physiochemical 
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properties of the active agent, such as its solubility, partition coefficient and diffusibility across 
the polymeric matrix.
96
 
The term controlled release includes different types of release profiles such as sustained release, 
triggered release, pulsed release and targeted release.
97
 There are several release mechanisms by 
which the core material is being gradually liberated out of the microcapsules, and in general, the 
release mechanism depends on the intended application of the microcapsules.
19
 The following 
are examples of the main release mechanisms associated with microencapsulation: 
1. Diffusion through the wall material 
Diffusion involves the penetration of the shell material by the dissolution fluid surrounding the 
microcapsules, which subsequently dissolves the core and results in the leaking out of the core 
material through the pores or interstitial channels of the wall material.
17
 Diffusion is the most 
commonly involved release mechanism in pharmaceutical preparations as it allows for the 
sustained release of the microencapsulated drug.
17,19
 
2. Dissolution of the wall material 
In this mechanism, the release of the active agent occurs when the coating material dissolves in 
the dissolution fluid. The thickness of the microcapsule wall and its degree of solubility in the 
dissolution fluid determines the release rate.
17
 This release mechanism is typically utilized in 
detergent preparations where the dissolution of the wall material of the microcapsules in the 
detergent powder liberates the encapsulated protease enzyme which has the ability to remove the 
stains from clothes. It is also utilized widely in the food industry, where microencapsulated 
ingredients such as nutrients, taste enhancers, or flavoring agents (e.g., in chewing gums) are 
liberated through the melting of the wall material.
19
 
3. Mechanical rupture of the wall 
The mechanical rupture of the microcapsule shell immediately releases the core contents. The 
rupture can be either achieved by applying pressure (such as in carbonless copy paper) or by 
scratching (as in case of scratch and sniff perfumes).
19
  
4. Degradation and Erosion of the wall  
The erosion of certain coating materials causes the gradual release of the core material.
17,98
  
Erosion can be classified into surface and bulk erosion, according to the chemical structure of the 
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polymer. When the rate of the polymer erosion is higher than the rate by which water permeates 
into the bulk of the polymer, the erosion is said to be surface erosion and the release follows zero 
order kinetics. However, bulk erosion occurs when the rate of water permeation is higher than 
the polymeric system erosion causing complex release kinetics.
99,100
 The majority of the 
biodegradable polymers exhibit bulk erosion. Erosion is a physical phenomenon that depends on 
diffusion and dissolution, whereas degradation is a chemical phenomenon. The degradation of 
the majority of the biodegradable polymers occurs by the bulk hydrolysis of the polymer into 
smaller fragments. Nevertheless, some biodegradable polymers, such as polyanhydrides and 
polyorthoesters, degrade only at the surface, exhibiting a release rate for the core material 
proportional to the surface area of the coating material. 
100
 
2.6. Applications of microencapsulation 
2.6.1. Food Industry 
Microencapsulation technology has recently been employed in the food industry.
20
 It allows for 
the incorporation of important ingredients, such as flavoring agents, polyphenols, vitamins, 
volatile additives, antioxidants and enzymes in different food products, and thus protecting these 
ingredients from degradation. Microencapsulation is also used in food packaging technologies 
where it permits the incorporation of antimicrobial agents in the packaging material to protect 
food against different foodborne pathogens.
5
 It is also used in the food industry to retard the rate 
of evaporation of volatile cores to the surrounding environment or to control their release rate 
over time or until reaching a specific stimulus.
11
 In addition, microencapsulation is applied in the 
food industry to mask the flavor of the core material; to separate different components that are 
reactive with one another within the product; or to modify the physical characteristics of the core 
material so that it becomes easier and more convenient to handle.
1,11
 Microencapsulation of 
probiotic bacteria has been recently used to enhance their bioavailability and targeted delivery in 
the gastrointestinal tract.
101
  
2.6.2. Pharmaceuticals 
Microencapsulation has various applications in the pharmaceutical industry. It provides a lot of 
advantages over the conventional drug systems, such as sustained release, protection of the drug, 
prolongation of shelf-life and targeted drug delivery.
4
 It is also used to mask the unpleasant taste 
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of some components in the pediatric and geriatric drug formulations.
102
 Bioencapsulation is one 
of the important pharmaceutical and medical applications of microencapsulation. It involves the 
entrapment of biologically active materials, such as DNA and cells. Encapsulation of DNA 
vaccines in polymeric microcapsules, such as poly lactic-co-glycolic acid (PLGA), offers slow 
release rate, and thus prolonged immune response.
4
 Another example includes the encapsulation 
of certain human tissues by natural polymers prior to their transplantation to manage some 
hormone deficient diseases (e.g., diabetes).
8
   
2.6.3. Cosmetics 
Microencapsulation in cosmetics covers a wide range of applications, including hair and skin 
care and maintenance products, oral cavity and mucous membrane products (e.g., toothpaste), 
perfumes, hair products, cleansing products, correcting body odor products, makeup and 
decorative cosmetics.
103
 Innovation, cost, and meeting the consumer demands drive the 
microencapsulation research and development in the cosmetic industry and perfumery.
22,104
 
There are various examples of core ingredients that are being microencapsulated in cosmetics, 
such as skin moisturizers, vitamins, essential oils, antimicrobials, and colorants.
9,103,105
 
2.6.4. Agriculture 
Microencapsulation is widely applied in the area of agriculture; either for crop protection
106
 or 
promoting plant growth.
19
 Microencapsulation of nitrogen-fixing bacteria in biodegradable 
polymers was investigated in one of the recent studies using spray drying methods which help in 
the growth of plants without the use of excessive chemical fertilizers.
107
 Furthermore, 
microencapsulation of pesticides and insecticides allows for plant protection while reducing 
human, animal and soil toxicity.  Additionally, it helps in elongating the duration of activity of 
the pesticide and controls its rate of evaporation.
108
 
2.6.5 Textiles  
The application of microencapsulation in textile industry started in the early 90s; with very few 
commercial products. However, by the beginning of the 21
st
 century, the number of applications 
has shown a visible growth, specifically in Japan, North America, and the countries of Western 
Europe.
109
 Microencapsulation permits the incorporation of different active agents onto textiles, 
and thus provides an added value to them. The core material is responsible for the new properties 
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of the fabric, and hence defines its function. Examples of microencapsulation applications in 
textiles include durable fragrances, skin softeners, vitamins, insect repellents, phase-change 
materials, color changing fabrics, cosmetotextiles, and medical textiles.
109,110
 
Different attempts to incorporate aroma onto textiles have been carried out for many years. 
Microencapsulation allows for higher durability and release of fragrances over a longer period. 
Fragrant textiles are frequently used in aromatherapy; a field which relates fragrances with 
psychology and how they can trigger specific feelings, such as happiness, relaxation, excitement, 
or well-being.
111
 Numerous essential oils such as, lavender, citrus, vanilla and rose have been 
applied to fabrics designed for aromatherapy. Each essential oil is reported to initiate a particular 
emotion and acts as a healing element.
112
 
‘Cosmetotextiles’ is a term given to fabrics designed to be in direct contact with the skin, and 
contain personal care active agents, such as skin softeners, slimming agents, moisturizers, anti-
cellulite, UV-protecting and anti-ageing ingredients.
113-115
 Those active ingredients are integrated 
in the fabrics by microencapsulation techniques, and are released to the skin by mechanical 
means, such as friction and abrasion.
113
 
Imparting antimicrobial properties to textiles has been one of the important applications of 
microencapsulation in textile industry. Textiles that are made of natural fabrics, such as cotton 
and wool are known to furnish excellent media for microbial growth due to their ability to hold 
humidity and highly porous structure that increases their surface area.
41,116
 A myriad of 
antimicrobial substances have been incorporated onto textiles. Natural antimicrobials have 
recently gained increasing interest due to their being safe, eco-friendly and originating from 
renewable sources. 
Another important textile application of microencapsulation is in the area of defense where 
chemical decontaminants are microencapsulated within certain polymeric shells. Theses shells 
are selectively permeable to toxic substances and partially permeable for the decontaminating 
core materials, and hence allowing the diffusion of the toxic chemicals into the core of the 
microcapsules where they become irreversibly detoxified by means of chemical reactions.
19
 
The process of adhesion of the microcapsules onto the fabric is an important factor to consider in 
microencapsulation application in textiles; because it directly affects the stability and the 
durability of the finished product. There are different methods by which microcapsules can be 
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applied to the fabrics, such as spraying, foaming, grafting through chemical links,
60
 
impregnation,
117
 coating, printing, padding and bath exhaustion. Padding is usually followed by 
drying and curing of the treated fabrics, and hence, the conventional process is known as the pad-
dry-cure method. The most widely used binding method in industry is padding. It involves 
soaking of the fabric in a bath that contains the microcapsules, resin and water and then passing 
the fabric through a padder (foulard). This subsequently entails applying a stream of hot air as a 
thermal treatment to cure the binding resin and adhere the microcapsules to the fabric. 
118
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Chapter 3: Materials and Methods 
3.1. Materials 
The reagents and chemicals used in the preparation and characterization of the microcapsules are 
listed in table 3.1.  
Table 3.1 List of used chemical compounds, their functions and suppliers. 
Chemical Compound Function Supplier 
Gum Arabic Wall material  Sigma Aldrich 
Chitosan (Degree of 
deacetylation 88-95%) 
Wall material  BioLog Biotechnologie 
Und Logistik GmbH 
(Germany) 
Vanillin Core material Sigma Aldrich 
(R)-(+)-Limonene Core material  Sigma Aldrich 
Tween® 20 Emulsifier Sigma Aldrich 
Tergitol, type 15-S-9 Emulsifier Sigma Aldrich 
Span 85 Emulsifier Sigma Aldrich 
PGPR 4150 Emulsifier Palsgaard
®
 (Denmark) 
Corn oil Carrier and solvent for vanillin Sigma Aldrich 
Hydrochloric acid 0.2 N pH adjustment Sigma Aldrich 
Acetic acid 0.1 N Solvent for chitosan Sigma Aldrich 
Sodium TPP Hardening agent Sigma Aldrich 
Tannic acid Hardening agent Merck 
n-Hexane Washing reagent  Carlo Erba Reagents  
Citric acid Grafting  of microcapsules onto 
fabrics  
Sigma Aldrich 
Sodium phosphate 
monobasic monohydrate 
Catalyst for grafting reaction Sigma Aldrich 
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Table 3.2 lists the cotton fabrics that were used for the application of the produced 
microcapsules. Fabrics dimensions were chosen according to the required impregnation method 
(whether simple coating or thermofixation method). All the fabrics were purchased from SDC 
Enterprises Limited, UK. 
Table 3.2 List of the cotton fabrics used. 
Fabric Dimensions Product Code 
Cotton Lawn 30cm x 25cm 1305 SDC  
Cotton Lawn Rubbing Fabric 20cm x 10cm 1351 SDC   
Cotton Limbric Gimped 10cm x 4cm 1531 SDC 
3.2. Experimental Methods 
3.2.1. Production of Microcapsules 
The process of both vanillin and limonene microcapsule formation involved three main steps: 
emulsification, complex coacervation induction and finally, the hardening of the formed 
microcapsules. Owing to the fact that vanillin is in a solid form and hydrophobic, corn oil was 
used to dissolve it and to permit its emulsification. Several preliminary formulations were 
produced until a final optimized formulation was obtained. These trials will be discussed in 
chapter 4, whereas the final microencapsulation formulation is discussed in this section. The 
method for the production of microcapsules was adapted from procedures described in previous 
reports
1,2
 but with some modifications.  
3.2.1.1. Production of Vanillin Microcapsules 
1. Emulsification 
1.0% (w/v) of chitosan solution was prepared by dissolving 0.5 g of chitosan in 50 mL of 0.1N 
acetic acid and was left overnight to be completely dissolved. 0.12 g of vanillin was dissolved in 
4.5 g of corn oil which was heated at 40°C and was added to the chitosan solution. 50 mL gum 
Arabic solution (2.0%, w/v) (which was prepared in deionized water), and a specified amount of 
the emulsifier was added to the mixture. Then, emulsification was generated by continuous 
mechanical agitation; through keeping the system under stirring at 8000 rpm with a homogenizer 
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(an ultraturrax IKA DI 25 Basic, yellow line) (Figure 3.1; Table 3.3), for 1 minute at 40⁰C to 
form an O/W emulsion. 
2. Induction of complex coacervation 
Complex coacervation was initiated by decreasing the stirring speed to 400 rpm, and the pH 
value of the mixture was adjusted from 6 to 3.5 with 0.2 N HCl. The mixture was left under 
continuous stirring for 30 minutes, and then it was cooled to 5⁰C by means of an ice bath. 
3. Hardening of microcapsules 
Consolidation of the produced microcapsules was done by the dropwise addition of the 
hardening agent (either solution sodium TPP or tannic acid) to the suspension of the 
microcapsules with continuous stirring (400 rpm) for 3 hours at 5⁰C. The microcapsules mixture 
was then left for decantation to allow phase separation. 
 
Figure 3.1 IKA
®
 DI 25 Basic Ultraturrax.  
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Table 3.3 Specifications of the homogenizer used in the formation of microcapsules.
3
 
Manufacturer IKA 
Model DI 25 Basic 
Dispersion tool working range 10-1500 ml 
Speed range 8000-24000 rpm 
 
3.2.1.2. Production of Limonene Microcapsules 
The final method used to produce limonene microcapsules was similar to that used for the 
preparation of vanillin microcapsules by complex coacervation (in Section 3.2.1.1), except for 
the volume and nature of the core material. Being a liquid, limonene was used directly as the oil 
phase in the O/W emulsion without the need to dissolve it in a suitable oil, as was previously 
done with vanillin.  
1. Emulsification 
1.0% (w/v) of chitosan solution was prepared by dissolving 0.5 g of chitosan in 50 mL of 0.1N 
acetic acid and was left overnight. One gram of limonene was added to the prepared chitosan 
solution. Then 50 mL gum Arabic solution (2.0%, w/v) (which was prepared in deionized water), 
and a specified amount of the emulsifier was added to the mixture. The system was maintained 
under stirring at 8000 rpm with the homogenizer for 1 minute at 40⁰C to form O/W emulsion. 
2. Induction of complex coacervation 
To start complex coacervation, the stirring speed was set to 400 rpm, and the pH value of the 
mixture was adjusted from 6 to 3.5 with 0.2 N HCl. After stirring for 30 min, the mixture 
solution was cooled gradually to 5⁰C by means of an ice bath. 
3. Hardening of microcapsules 
The method used for the hardening of vanillin microcapsules was also applied for limonene 
microcapsules (Section 3.2.1.1) and the microcapsules mixture was then left for decantation to 
allow phase separation. 
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3.2.2. Characterization Methods 
3.2.2.1. Optical Microscopy 
The morphology of the obtained microcapsules was examined by means of a Leica DM 2000 
optical microscope equipped with Leica Application Suite Interactive Measurement imaging 
software (Figure 3.2). Different magnifications (100x, 200x, 400x, and 1000x) were used to 
observe the produced microcapsules.  
 
Figure 3.2 Optical microscope, Leica DM 2000.  
3.2.2.2. Particle Size Evaluation 
Mean particle size and size distribution of the produced microcapsules were determined by a 
Beckman Coulter Laser Diffraction Particle Size Analyzer LS 230 (Figure 3.3). The Coulter LS 
200 Series uses reverse Fourier lens optics incorporated in a binocular lens system, which 
enables the optimization of light scattering across a wide size range in a single scan with high 
data reproducibility.
4
 The size distribution measurements were done in both volume and number 
for all samples. 
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Figure 3.4 Laser Diffraction Particle Size Analyzer, Beckman Coulter LS 230. 
3.2.2.3. Scanning Electron Microscope (SEM) 
A high-resolution (Schottky) Environmental Scanning Electron Microscope with X-Ray 
Microanalysis and Electron Backscattered Diffraction Analysis: Quanta 400 FEG ESEM/EDAX 
Genesis X4M operating at 15.00 kV was used to examine the morphological features of the 
produced microcapsules (Figure 3.5). Microcapsules were freeze-dried and then coated with a 
thin film of gold and palladium, by sputtering, using the SPI Module Sputter Coater equipment 
(Figure 3.6) prior to SEM analysis. Textile samples were directly examined without being 
previously coated. 
For some SEM examinations, a Phenom ProX desktop scanning electron microscope (Figure 
3.7), equipped with Elemental Identification (EID) software with Energy Dispersive 
Spectrometer (EDS) was used. 
Freeze-drying was done by placing the microcapsules for 24 hours in a Scanvac CoolSafe 55-4 
Basic 4lt freeze dryer, operating at about -50ºC and 0.2 mbar, after being separated by 
decantation. 
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Figure 3.5 Scanning electron microscope FEI Quanta 400 FEG ESEM / EDAX Genesis X4M.
5
 
 
Figure 3.6 SPI-Module™ Sputter Coater of the Materials Center of the University of Porto. 
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Figure 3.7 Phenom ProX desktop scanning electron microscope. 
3.2.2.4. Gas chromatography (GC-FID)  
Gas chromatography (GC-FID) was used to quantify the encapsulated and the released vanillin 
and limonene. A Varian CP‐3800 gas chromatographer equipped with split/splitless injector, two 
CP‐Wax 52CB bonded fused silica polar columns (50 m x 0.25 mm with 0.2 μm film thickness) 
and a Varian FID detector operated by the Saturn 2000 WS software was used for the analysis 
(Figure 3.8). The injectors were set at 240°C, with a split ratio of 1:50 for FID. The FID detector 
was maintained at 250°C. The volume of each injected sample was 0.1μL. The carrier gas was 
helium He N60 with a constant flow rate of 1 mL/min. 
For the analysis of vanillin, the oven temperature was kept isothermal at 50°C for 5 minutes, and 
then increased gradually from 50°C up to 120°C at a rate of 10°C/min, followed by a second 
gradual increase to 200°C with a rate of 2°C/min. The total running time for a sample was 73 
minutes. 
During limonene quantification, the oven temperature was maintained isothermal at 175°C for 7 
minutes, and then increased to 220°C with a rate of 10°C /min with a hold of 5 minutes. The total 
running time for each sample was 16.5 minutes. 
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Figure 3.8 Varian CP‐3800 GC/FID equipment. 
3.2.2.5. pH Measurement   
Determination of pH was done by a Crison pH meter, model Basic 20 (Figure 3.9), which was 
calibrated to pH 4, pH 7 and pH 9 prior to all experiments.                     
 
Figure 3.9 Crison Basic 20 pH meter. 
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3.2.2.6. Solid Content Determination 
Solid content of the microcapsules was determined according to the European Standard EN 827 
for the determination of solid content in a water based adhesive. It involves measuring the 
difference between the initial mass and the final mass of microcapsules samples after water 
evaporation. The test was done by placing about one gram of the microcapsule suspension on a 
watch glass and allowing it to be dried in an oven at 100°C for 30 minutes, then placing the 
sample in a desiccator for 15 minutes and weighing the residual mass. The drying step was 
repeated until the difference between the initial mass and the residual mass (mass final) did not 
exceed 2 mg.
6
 The solid content was calculated according to equation 3.1: 
% Solid Content = mass final     x 100                                                            (3.1)  
                           mass initial  
3.2.3. Release Measurements 
The release studies of vanillin and limonene were performed by using the produced 
microcapsules suspensions after being washed with hexane. The measurements involved 
quantification of the free active material (vanillin or limonene) after being released from the core 
of the microcapsules to the microcapsules surrounding phase. The method was adapted from a 
previously reported study,
7
 but with few alterations.  
Throughout the work, known volumes of washed microcapsules were placed in sealed bottles 
and placed in an incubator (Figure 3.10), which was set to specific temperatures and shaking 
speeds over a certain duration of time. Samples of the incubated microcapsules suspensions were 
collected at predetermined time intervals. Subsequently, the microcapsules surrounding phase 
was separated from the loaded microcapsules in the suspension by a syringe equipped with a 0.2 
µm pore size polypropylene filter (VWR International - Material de Laboratório, Lda). The 
concentration of the free vanillin and limonene in the filtered microcapsules surrounding phase 
was eventually measured by GC-FID chromatography. Vanillin and limonene release profiles are 
presented and discussed in detail in chapter 5. 
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Figure 3.10 SI-300R Lab Companion Incubator Shaker. 
3.2.4. Fixation of Microcapsules onto Fabrics 
3.2.4.1. Simple coating method 
Cotton fabrics (10 cm x 4 cm) were submerged in the microcapsules suspension for five minutes 
and then were left to dry at room temperature. Samples were cut from different locations on each 
fabric. SEM was used to confirm the presence and evaluate the morphology of the microcapsules 
on the fabrics. Elemental analysis of the chemical constituents of the microcapsules that coated 
the fabric was also done by SEM. 
 3.2.4.2. Grafting followed by pad-dry-cure method 
The application of microcapsules onto the fabrics was also carried out by a chemical grafting 
method followed by an impregnation process using a ‘pad-dry-cure’ technique. The method was 
adapted from a previous report.
8
 The chemical adhesion process involved the use of citric acid as 
the linker, and sodium hypophosphite as a catalyst. The padding step was done by a Roaches 
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foulard, model EHP Padder (Figure 3.11). The padding pressure varied between 0.1 MPa and 0.3 
MPa, followed by a drying process in a Roaches thermofixation oven (Figure 3.12), in which the 
treated samples were adjusted on a pin frame and exposed to a recirculating heat current that 
allowed optimized drying and curing of the microcapsules at different selected temperatures for 
specific time. 
 
Figure 3.11 Roaches EHP Padder, the laboratory foulard used in the fixation of the formed 
microcapsules onto the fabrics. 
 
Figure 3.12 Roaches laboratory thermofixation oven, model Mini Thermo.  
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Chapter 4: Production and Characterization of Vanillin and Limonene 
Microcapsules by Complex Coacervation  
4.1. Introduction 
Complex coacervation is one of the most suitable methods used to encapsulate fragrances and 
flavors; because it reduces or prevents the loss of the volatile compounds since it does not 
require high temperature.
1
 In spite of the fact that the exact mechanism has not yet been fully 
elucidated, complex coacervation is regarded as a phase separation process that depends on 
complex formation between oppositely charged polymers via electrostatic attractions, formation 
of hydrogen bonds or hydrophobic interactions.
2
 The majority of the studies reported in literature 
have investigated the combination of a protein and a polysaccharide in complex coacervation, 
namely gelatin (an example of a positively charged polymer) and gum Arabic (an example of a 
negatively charged polymer). Gelatin/gum Arabic is considered the most common pair of 
complex coacervation and has been widely applied in carbonless paper production and in the 
encapsulation of flavors and fragrances.
3
 However, due to some religious and ethnic constraints
4
, 
and some health concerns related to emerging diseases, such prion diseases, the use of gelatin is 
sometimes not preferred and is replaced with a different positively charged polymer, which can 
be a protein or a polysaccharide.
3
 
A cross-linking agent is added in the last step of the coacervation process to harden the formed 
shells of the microcapsules and stabilize their structure.
5
 Formaldehyde and glutaraldehyde are 
widely used as hardening agents for the microcapsules, and are reported to be toxic and are 
banned in some countries.
6
 Thus, they are being replaced with eco-friendly hardening agents. 
Moreover, it has been reported that when glutaraldehyde was used to harden the microcapsules 
of gelatin and gum Arabic, the crosslinked microcapsules had a tendency to aggregate and 
showed a poor state of dispersion.
7
 Therefore, the use of safe and eco-friendly microcapsules 
hardening agents has recently substituted these conventional cross-linking agents. These 
hardening agents include sodium tripolyphosphate
8
, tannic acid, glycerol, transglutaminase and 
genipin.
2,9
 
In the work presented here, sodium tripolyphosphate and tannic acid (Figure 4.1) were examined 
individually as hardening agents instead of the conventional aldehyde compounds. Sodium 
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tripolyphosphate (TPP) is a multivalent anion; carrying five negative charges and hence, is able 
to interact with the positively charged –NH3
+ 
groups of chitosan through electrostatic 
attraction.
8,10
 Sodium TPP is a non-toxic FDA approved compound and is ‘generally regarded as 
safe’ (GRAS).11 
Tannic acid is a natural plant polyphenol, which has the ability to bind to polymers, e.g., gelatin, 
carrageenan and chitosan through hydrogen bonding and hydrophobic interactions.
7,12-14
 
 
Figure 4.1 Structure of (a) sodium TPP and (b) tannic acid. Adapted from Ref. 10 and 14. 
According to their internal structure,
15
 microcapsules can be classified into two types either 
reservoir or monolithic (Figure 4.2). Reservoir microcapsules can be either mononuclear or 
polynuclear (multinuclear), whereas the monolithic microcapsules are formed of a matrix of the 
internal phase and the wall material.
16
  
 
 
Figure 4.2 Types of microcapsules. Adapted from Ref.16. 
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Mononuclear microcapsules are produced when an oil droplet becomes encapsulated with the 
polymer(s) whereas the polynuclear microcapsules are formed as a result of aggregating 
mononuclear microcapsules.
5,15
 This aggregation can be hindered by modifying the hardening 
process, using particular wall materials or making changes in the coacervation process 
parameters.
15
 It has been reported in literature that the change in the agitation speed of dispersion 
during the preparation of the microcapsules by complex coacervation could lead to the change in 
their morphology. According to Jégat et al,
17
 multinuclear microcapsules were formed when low 
stirring speed was applied (less than 1000 rpm) while the proportion of mononuclear 
microcapsules increased when the speed exceeded this value. Nevertheless, Dong et al.
15
 
obtained multinuclear microcapsules by complex coacervation when a stirring speed of 10,000 
rpm was applied for 3 minutes.  
Current investigations on microencapsulation by coacervation typically focuses on mononuclear 
microcapsules and overlooks the study of the polynuclear microcapsules, although the 
polynuclear microcapsules have been recently reported to exhibit better sustained release than 
the mononuclear ones.
5,15
 
Factorial designs are often applied in the experiments related to the microencapsulation research. 
These designs involve changing one factor, which will act in an additive manner when keeping 
the other variables constant within the same study.
18
 
This chapter investigates the encapsulation of vanillin and limonene by complex coacervation 
method using chitosan/gum Arabic as encapsulants. Two green hardening agents; tannic acid and 
sodium tripolyphosphate were investigated and their effect on the microcapsule size, morphology 
and encapsulation efficiency was examined. Moreover, the influence of different emulsifiers 
(Tween 20, Tergitol, Span 85 and polyglycerol polyricinoleate (PGPR)) on the morphology, 
dispersion, encapsulation efficiency and the size of the formed microcapsules were studied. 
4.2. Materials and Methods 
4.2.1. Materials 
The chemical compounds and reagents used in this chapter were previously mentioned along 
with their suppliers in Chapter 3, Section 3.1. 
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4.2.2. Methods  
The general method of the preparation of the microcapsules is comprised of four main steps and 
was adapted from some methods previously described in the literature
8,19,20
 but with some 
modifications that principally involved changing the type and amount of the core material, along 
with the type and amount of the emulsifier and the masses of the chitosan and gum Arabic used. 
The preparation process of the microcapsules is schematically illustrated in Figure 4.3. 
The first step involved the dissolution of certain amount of chitosan and gum Arabic. 1% (w/v) 
chitosan solution was prepared by dissolving known amount of chitosan in 0.1N acetic acid and 
left under magnetic stirring overnight (15 hours) to ensure complete dissolution. 2% (w/v) gum 
Arabic solution was obtained by dissolving certain amount of gum Arabic in deionized water 
with continuous magnetic stirring at 45ºC for 2 hours. 
In the second step, the polymer solutions were mixed together and a known amount of the core 
material with a known volume of the emulsifier were added to them. Then, they were all mixed 
at a speed of 8000 rpm at 40ºC for 1 minute with a homogenizer to form an O/W emulsion. 
Taking into consideration that vanillin is in the form of solid crystals; so it was previously 
dissolved in a certain amount of corn oil at 40ºC in a covered beaker for 10 minutes before being 
added to the mixture. 
 
Figure 4.3 Schematic representation of the method of microcapsules preparation. 
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The third step entailed the induction of complex coacervation by decreasing the pH value to 3.5 
with 0.2N HCl and setting the stirring speed of the formed emulsion to 400 rpm. Complex 
coacervation is strongly affected by the pH, and it is reported in the literature that the interaction 
between chitosan and gum Arabic is maximized within a pH range of 3.5 to 5.
21
 The pH in this 
study was reduced to 3.5; because chitosan has a maximum amount of positive charge in the pH 
range of 2.8 to 4, and gum Arabic has negative charges only if the pH is above 2.2.
8
 After 30 
minutes of continuous magnetic stirring, the temperature was gradually decreased from 40ºC to 
5ºC with the help of an ice bath. 
The last step involved the hardening of the formed microcapsules by drop wisely adding the 
cross-linker solution (tannic acid or sodium TPP) at 5ºC and stirring at 400 rpm for 3 hours. 
Sodium TPP solution was prepared by dissolving a specific amount in deionized water followed 
by the adjustment of pH from 8 to 3.5 by 0.2N HCl before adding it to the final microcapsules 
mixture. The ratio of sodium TPP to chitosan in all formulations was 1:2 (wt%). 
Here we discuss 15 formulations that were prepared by using either vanillin or limonene as the 
core material and examining different emulsifiers (Tween
®
 20, Tergitol 15-S-9, Span 85, Tween 
80 and PGPR) and two hardening agents separately (tannic acid and sodium TPP). The chemical 
system of each formulation is summarized in Table 4.1. 
4.2.3. Characterization of Microcapsules 
The morphology and the dispersion of the microcapsules were investigated by optical 
microscope and the mean particle size was determined by laser diffraction particle size analysis. 
The encapsulation efficiency of microcapsules was determined by the quantification of the non-
encapsulated vanillin or limonene with GC-FID analysis and calculating the masses of the 
encapsulated core agents through a method reported previously in Chapter 3 (Section 3.2.2.4.). 
4.3. Results and discussion 
4.3.1. Encapsulation efficiency 
The encapsulation efficiency (EE %) was determined using the following equation: 
EE%= mass (total) - mass (non-encapsulated) x 100                                          (4.1) 
                           mass (total) 
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The values of EE % of the formulations are shown in Table 4.1. 
Table 4.1 The chemical systems and the EE% of the formulations. 
Formulation Active 
agent 
Amount 
(g) 
C GA Emulsifier 
Amount 
(g) 
Hardening 
agent 
Amount 
(g) 
EE% 
1 V 0.3* 2 8 Tween 20 2.58 TPP 1 64.2 
2 V 0.3* 2 8 Tergitol 2.58 TPP 1 62.0 
3 V 0.3* 2 - Tween 20 2.58 TPP 1 30.2 
4 V 0.02** 0.5 1 PGPR 0.35 TA 0.2 93.4 
5 V 0.12*** 0.5 1 PGPR 0.6 TA 0.2 95.2 
6 L 1 0.5 1 PGPR 0.35 TA 0.2 90.4 
7 L 4.5 0.5 1 PGPR 0.6 TA 0.2 94.1 
8 L 1 0.5 1 PGPR 0.35 TA 0.4 97.3 
9 L 4.5 0.5 1 Span 85 0.6 TA 0.2 98.7 
10 L 1 0.5 1 Span 85 0.35 TA 0.2 98.6 
11 L 1 0.5 1 Span 85 0.35 TPP 0.2 -- 
12 L 1 0.5 1 PGPR 0.35 TPP 0.25 85.3 
13 V 0.02*** 0.5 1 Span 85 0.35 TA 0.2 100 
a 
14 V 0.12*** 0.5 1 Tween 20 0.6 TA 0.2 -- 
15 V 0.12*** 0.5 1 Tween 80 0.6 TA 0.2 -- 
V=vanillin, L=limonene, C=chitosan, GA= gum Arabic, TA= tannic acid, TPP=tripolyphosphate 
a 
 GC/FID peak for the non-encapsulated vanillin could not be detected, and thus the 
concentration and mass of the non-encapsulated vanillin was considered zero. 
*0.3 g vanillin was dissolved in 20 ml corn oil 
**0.02 g vanillin was dissolved in 1 g corn oil 
***0.12 g vanillin was dissolved in 4.5 g of corn oil; amount of corn oil is comparable to 
limonene. 
Comparing the EE% of the first three formulations (where one factor in each was changed and 
the others were kept the same), it could be observed that the values showed no big difference 
when Tergitol was used as the emulsifier instead of Tween 20. However, when the wall material 
contained only chitosan (formulation 3) and no gum Arabic was included, there was a dramatic 
decrease in the EE% from 64.2% to 30.2%. This indicates that the presence of gum Arabic in the 
shell material along with chitosan not only adds to the compactness and strength of the 
microcapsules wall, but also increases the EE%. It could be also explained in terms that the 
availability of more polymers in the formulation mixture results in encapsulating higher amounts 
of core materials.
1
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The use of sodium TPP as hardening agent resulted in the appearance of dark patches, perhaps of 
polymer precipitation, that could be seen when the formulations were examined by the optical 
microscope without centrifugation (Figure 4.4). 
It was also noticed that formulations which contained vanillin as the core material generally had 
higher EE% than those which contained limonene. This could be observed when comparing the 
formulations that contained the same amounts of limonene and corn oil that was used to dissolve 
certain amounts of vanillin, i.e., formulations 4, 5 and 12 with formulations 6, 7 and 9 
respectively. (In these formulations, the preparation conditions and chemical systems were kept 
the same and only the core material was changed). This might be because vanillin was dissolved 
in corn oil that resulted in decreasing its diffusivity through the wall and more core material was 
successfully encapsulated. In contrast, in the case of limonene microcapsules limonene was used 
purely as the core material, and hence diffused more readily. 
The hydrophilic-lipophilic balance (HLB) is a numerical value that reflects the composition of 
the emulsifier, regarding its content of the hydrophilic and hydrophobic moieties. Emulsifiers 
with low HLB values (4.7-6.7) are usually used to obtain w/o emulsions, whereas o/w emulsions 
are obtained by emulsifiers with higher HLB values (9.6-17.6).
22
 However, some articles in the 
literature reported the formation of o/w emulsion followed by complex coacervation by using 
emulsifiers with low HLB values (e.g., Span 83).
19
 It was noticed in this work that the 
formulations prepared with Span 85 (HLB=1.8) emulsifier exhibited relatively higher EE% than 
formulations prepared with PGPR (HLB=2-4) that had the same other preparation factors. This 
could be observed by comparing the EE% of vanillin formulations 5 and 12 (95.2% and 100%), 
and limonene formulation pairs 6 and 10 (90.4% and 98.6%), 7 and 9 (94.1% and 98.7%). These 
results are in agreement with those obtained by Rabisková et al
23
 who stated that the use of 
emulsifiers with low HLB values (1.8 and 6.7) in the preparation of o/w emulsions for complex 
coacervation results in higher values of EE%, indicating the preference of the encapsulation of 
hydrophobic materials for emulsifiers with low HLB value. The authors reported the inability of 
emulsifiers with high HLB values, such as Tween 81 and Tween 80 (HLB=10 and 15, 
respectively) to encapsulate oils by complex coacervation using gelatin and gum Arabic as wall 
materials.  
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The encapsulation efficiency obtained by using tannic acid as hardening agent in this study 
ranged between 90.4% and 100%.  This is significantly higher that what was reported by Pakzad 
et al
12
; who obtained an EE% falling in the range of 53% to 80% by using tannic acid as a 
hardening agent for menthol microcapsules produced by complex coacervation using gum 
Arabic and gelatin as the wall materials. Comparing the EE% of limonene formulations 6 and 12, 
in which only the type of the hardening agent was different and all the other formulation factors 
were kept the same, it was found that tannic acid resulted in a higher encapsulation efficiency 
(EE% of formulation 6=90.4%) that sodium tripolyphosphate (EE% of formulation 12= 85.3%). 
This suggests that tannic acid has higher ability to cross-link with the microcapsules walls than 
sodium tripolyphosphate. Additionally, tannic acid did not result in the precipitation around the 
microcapsules that could be seen in the optical microscopy images of formulation 12 (Figure 
4.7.B). 
Increasing the amount of tannic acid from 0.2 g to 0.4 g in formulations 6 and 8, and keeping the 
amounts of all other ingredients constant, resulted in the increase of EE% from 90.4% to 97.3%. 
This is in line what was reported by Devi et al
13
 who observed an increase in the EE% from 
42.6% to 71.6% when the amount of tannic acid increased from 0.2 to 0.8 mmol, and explained 
that the increase in the EE% that occur by increasing the amount of the hardening agent is due to 
the presence of more cross-linkable groups able to form more covalent bonding with the 
polymers of the wall materials of the microcapsules, and thus making them have higher core 
material retention ability. 
4.3.2. Optical microscopy 
It was observed from the optical microscope images of the formulations that the type of the 
emulsifier used had an influence on the dispersion of the microcapsules and their morphology. 
Formulations obtained by the emulsifier Tween 20 (HLB=16.5)
24
 encountered formation of 
aggregates of the microcapsules which were mononuclear (Figure 4.4.A). The degree of 
aggregation increased when Tergitol (HLB= 13.3)
24
 was used instead of Tween 20. Tergitol also 
produced mononuclear microcapsules but with smaller particle size (Figure 4.4.B). Formulation 
3 that was produced with Tween 20 and using chitosan solely as the wall material (without 
adding gum Arabic) also had bunches-of-grapes-like aggregation (Figure 4.4.C), and had bigger 
size of microcapsules than formulation 1. 
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Figure 4.4 Optical microscope images of formulations: A) 1 (Tween 20), B) 2 (Tergitol) and C) 
3 (Tween 20 and no gum Arabic).  Images on the left show the emulsions and on the right side 
are the formulations after adding the hardening agent sodium TPP without sample centrifugation. 
Magnification: A) 200 x, B) 200 x and C) 400 x. 
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The appearance of this aggregation in formulation 3 indicated that the presence of gum Arabic in 
formulation 1 contributed to a better dispersion of the particles in the emulsion than in 3. 
Moreover, the absence of gum Arabic resulted in unstable formulation and the appearance of oil 
drops on the surface after 2 months. Gum Arabic has been reported in the literature to be highly 
beneficial in the stabilization of oil-in-water emulsions and preventing the flocculation of 
droplets during the storage at room temperatures; because of its ability to be adsorbed at the 
droplet surface.
25,26
 It could be noticed in the optical microscope images of the formulation 1, 2 
and 3, in which sodium TPP was used as hardening agent, the presence of a dark patches 
probably of polymer precipitation or gelation between sodium TPP and excess chitosan dissolved 
in the medium. The same dark precipitation was also observed when chitosan amount was 
reduced from 2g to 0.5g (formulation 11) and another emulsifier was used. However, this 
precipitation was removed by centrifugation in some preparations which allowed the 
measurement of EE%. 
All the formulations that were prepared with PGPR are rounded with polynuclear morphology 
(Figure 4.5). PGPR is a hydrophobic emulsifier (HLB=2-4), and its use to form polynuclear 
complex coacervate microcapsules through (w/o) or (w/o/w) emulsions has been reported in the 
literature.
27-29
 Polynuclear microcapsules are known to grant more protection for the 
encapsulated core material.
29
  Formulations prepared with Span 85 emulsifier (HLB=1.8) have 
shown mononuclear morphology and good dispersion without any aggregation (Figure 4.6). 
Moreover, the use of tannic acid as the hardening agent in these preparations resulted in the 
highest EE% values compared with other formulations. Nevertheless, when sodium TTP was 
used as the hardening agent instead of the tannic acid and Span 85 was kept as the surfactant 
(formulation 11), the dark patches of polymer precipitation appeared again (Figure 4.7.A.). It 
also appeared when sodium TTP was added to an emulsion obtained with PGR in formulation 
12, (Figure 4.7.B). It was observed that sodium TPP resulted in the aggregation of the 
microcapsules prepared with Span 85, which previously had good dispersion. Therefore, the 
hardening agent also seems to have a big influence on the dispersion of the final microcapsules; 
not just the emulsifier. Tannic acid was examined with formulations prepared with Tween 20 and 
Tween 80 (HLB=15) and appeared to be incompatible with these emulsifiers since it resulted in 
the flocculation of the microcapsules as shown in Figure 4.8. 
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Figure 4.5 Optical microscope images of vanillin and limonene microcapsules of formulations 
prepared with PGPR: A) 4, B) 5, C) 6 and D) 7. Magnification: A) 200 x, B) 200 x, C) 200 x and 
D) 200 x. 
 
Figure 4.6 Optical microscope images of limonene and vanillin microcapsules of formulations: 
A) 9 and B) 13, in which Span 85 was used as the emulsifier. Magnification: A) 400 x and B) 
400 x. 
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Figure 4.7 Optical microscope images of limonene microcapsules of formulations: A) 11 and B) 
12; prepared with Span 85 and PGPR, respectively, using sodium TPP as the hardening agent. 
Magnification: A) 100 x and B) 100 x. 
 
Figure 4.8 Optical microscope images of vanillin microcapsules of formulations: A) 14 and B) 
15; prepared with Tween20 and Tween 80, respectively, using tannic acid as the hardening 
agent, in same amounts. Magnification: A) 100 x and B) 100 x. 
 
4.3.3. Particle size 
It was observed that the type of the emulsifier greatly influenced the size of the microcapsules. 
Tergitol resulted in very small sized microcapsules, Tween 20 and Span 85 produced medium 
sized microcapsules and PGPR produced microcapsules with larger sizes than the formers. Table 
4.2 lists the mean diameter of the formulations that showed good dispersion. The particle size 
distribution was also affected by the core-wall ratio. In the present study, it was noticed that 
keeping the amount of wall materials constant and increasing the amount of oil used (from 1 to 
 62 
 
4.5 g) resulted in a significant increase in the mean diameter of the microcapsules which were 
prepared with the PGPR (Vanillin formulations 4 and 5 and limonene formulation 6 and 7). 
However, a very slight increase was noticed for the mononuclear microcapsules when Span 85 
was used (Formulations 9 and 10). The increase in the size of the microcapsules with increasing 
the core-wall ratio has been reported in the literature in preparations of microcapsules by 
complex coacervation.
19,20,29
 Dong et al.,
30
 stated that concerning the multinuclear microcapsules, 
the increase in the ratio of core to wall material results in an increase in the amount of emulsion 
droplets available in the suspension during the preparation, which subsequently forms larger 
spherical coacervate polynuclear microcapsules.  
It was also notable that increasing the amount of tannic acid from 0.2 g to 0.4 g (in formulation 6 
and 8) resulted in smaller size of microcapsules. This result is consistent with the findings 
obtained in the literature.
12,31
 This may be due to the fact that the availability of more tannic acid 
results in an increased degree of cross-linking with the wall materials and consequently makes 
the wall more compact and with smaller sizes. 
Table 4.2 Mean diameters of produced microcapsules. 
Formulation 
Mean diameter 
(µm) 
1 11.2 
2 4.1 
3 (-)* 
4 15.7 
5 38.2 
6 18.4 
7 39.0 
8 10.9 
9 12.9 
10 11.1 
11 (-)* 
12 35.4 
13 10.4 
14 (-)* 
15 (-)* 
(-)* Particle size of these formulations was not measured since they did not have good dispersion 
or did not seem stable. 
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4.4. Conclusion 
Here, the production of chitosan/gum Arabic microcapsules loaded with vanillin or limonene 
was successfully achieved by the complex coacervation method. The EE% value ranged from to 
62 to 100%, and was shown to be about 30% when gum Arabic was not included. The process 
parameters involved the examination of various emulsifiers with significant difference in their 
HLB values. Span 85 emulsifier resulted in the highest values of vanillin and limonene 
encapsulation, followed by PGPR and then Tween 20 (Span 85> PGPR> Tween 20). The type of 
the emulsifier also affected the morphological characteristics of the produced microcapsules; as 
Span 85 and Tween 20 resulted in the formation of mononuclear microcapsules whereas PGPR 
produced multinucleated particles. Two green hardening agents; sodium TPP and tannic acid 
were used separately to cross-link with the microcapsules shell materials. The type and amount 
of the hardening agent was found to affect the size and EE% as well as the dispersion of the 
particles in the final product. Formulations in which tannic acid was used as the hardening agent 
acquired higher EE% values than those which have been treated with sodium TPP.  
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Appendix 4.1: Particle size distribution charts of formulation 2. 
 
 
 
Figure 4.a Particle size distribution of microcapsules of formulation 2 in volume and in number. 
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Appendix 4.2: Calibration Curves for GC-FID Analysis 
 
Figure 4.b Calibration curve of standard limonene. 
 
Figure 4.c Calibration curve of standard vanillin. 
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Chapter 5: Release of Active Agents 
5.1. Introduction 
The controlled release of the active agents from the microcapsules intended for textile 
applications is crucial to be investigated. The release pattern should provide a slow release from 
the fabric microcapsules to the skin without overdosing, and at the same time maintaining a 
durable effect.
1
 In fact, the longer the time the active agent can be retained within the core of the 
microcapsules, the longer the shelf-life of the product/fabric would be.
2
 The characteristics of the 
polymers of the microcapsule wall, such as its type, thickness, swellability, degree of hardening, 
mechanical strength, and interactions between the wall polymers and the active agent all affect 
the diffusion, and hence, the release rate of the core material.
3,4
 
The controlled release based on diffusion processes can be described mathematically by release 
kinetics equations. The most frequently discussed release rate models in literature are the zero 
order, first order and square root order systems (Figure 5.1). The zero order kinetics involves the 
release of the core material at a constant rate over time until total depletion.
2,5
 The zero release 
can be expressed by the following simple equation:
6
 
Mt ∕M0= K0t                                                                                                      (5.1) 
where Mt is the amount of the core material/drug released at time t, M0 is the initial amount of 
the core material/drug in the solution and K0 is the zero order release constant. The plot of the 
zero release kinetics shows the percentage of cumulative release of core material/drug versus 
time.  
In the first order kinetics (Equation (5.2)),
7
 the release of the core material is relatively faster in 
the beginning, and then decreases with time.
2
 This kinetic model implies that the change in the 
concentration of the released core material/drug with time is dependent on the concentration. 
 Mt ∕M0= 1-e
-kt
                                                                                                   (5.2) 
The release profile in the square root order kinetics (Higuchi model) exhibits a behavior between 
the zero and first order models.
2
 The Higuchi diffusion model (Equation (5.3)) relates the 
concentration of the core material or drug released to the square root of time as follows: 
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Mt/M0= kH t
½
                                                                                                  (5.3) 
where Mt/M0 represents the fraction of the cumulative amount of the encapsulated material 
released in time t and kH is the Higuchi rate constant.
8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Graphical representation of the cumulative release of core material as a function of 
time. Adapted from Ref 2. 
The Higuchi model was first developed to relate the release of a drug from an ointment, but later 
it has been used to study the pseudo-steady diffusion of solid drugs from granular and 
homogenous matrices.
9
 The Higuchi model assumes that no interactions occur between the drug 
and the matrix, and that the diffusion coefficient is constant.
9,10
   
The Korsmeyer-Peppas release model was originally developed to describe the release of a drug 
molecule from a polymeric system. According to Korsmeyer et al., the release rate can be 
represented mathematically by the following equation:
10
 
Mt/M∞= Kk. t
n
                                                                                                 (5.4) 
where Mt and M∞  are the cumulative amounts of the drug in the release solution at time t and 
infinity, respectively, Kk is the release rate constant, and n is the diffusional exponent that 
describes the obtained release mechanism.
11
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The Korsmeyer-Pepppas equation is also called the “power law”; as the equation suggests that 
the fractional release of core material/drug is exponentially related to time, and the value of 
diffusional exponent (n) indicates the diffusional release mechanism of the core agent/drug from 
the polymer as shown in Table 5.1.
12,13
 
Table 5.1 The indicative values of the release exponent “n” of Korsmeyer-Peppas equation and 
the related release mechanism of the core material/drug from polymers of different geometries. 
Adapted from Ref. 12 and 13.  
 
In this chapter, limonene and vanillin microcapsules were prepared by complex coacervation 
method. Characterization of the produced microcapsules, regarding the size, morphology and 
encapsulation efficiency was evaluated. The cumulative release profiles and the release kinetics 
of the core materials were investigated. 
5.2. Materials and methods 
5.2.1. Materials 
Chitosan (Degree of deacetylation 88-95%) and gum Arabic were used as wall materials, and 
were purchased from BioLog Biotechnologie Und Logistik (Germany), and Sigma Aldrich, 
respectively. The molecular weight range of the chitosan used in all the formulations was 
between 80,000 and 200,000 Da as claimed by the manufacturer. Vanillin and limonene were 
separately used as the active agents, and were purchased from Sigma Aldrich. Three different 
emulsifiers were used Tween 20, Span 85 and Polyglycerol polyricinoleate (PGPR 4150). Tween 
20 and Span 85 were supplied by Sigma Aldrich, and PGPR was obtained as a gift from 
Palsgaard
®
, Denmark. Pure corn oil was purchased from Sigma Aldrich. Sodium 
tripolyphosphate (TPP) (Sigma Aldrich) and tannic acid (Merck) were used individually as 
hardening agents in different preparations. n-Hexane was used a washing reagent for the 
microcapsules and was supplied by Carlo Erba Reagents. 
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5.2.2. Microcapsules preparation 
Three release studies were conducted, each with two formulations produced by changing the 
amount of the wall material used, type of the emulsifier, and the hardening agent. The amounts 
and different types of materials used in each formulation are mentioned in each study. Vanillin 
and limonene formulations were produced independently by the complex coacervation method 
according to the general procedure detailed in Chapter 3 (Sections 3.2.1.1 and 3.2.1.2). 
5.2.3. Characterization of Microcapsules 
The morphology of the prepared microcapsules was examined by optical microscopy and the 
mean diameter of each formulation was determined by laser diffraction particle size analysis. 
The encapsulation efficiency of microcapsules was determined by quantifying the non-
encapsulated core material with GC-FID analysis and calculating the masses of the encapsulated 
active agents as reported previously in Chapter 3 (Section 3.2.2.4). 
The GC-FID injected samples were prepared by taking 2 ml from the whole formulation and 
then mixing them with a particular volume of n-hexane, followed by centrifugation at 3000 rpm 
for 5 minutes. This was performed to extract the non-encapsulated vanillin or limonene from the 
medium. The supernatant was then collected, filtered through 0.2 µm pore size polypropylene 
filter and a volume of 0.1 µL was injected in the GC.  
The encapsulation efficiency (EE %) was calculated as the difference between the total mass of 
the core material initially used for each preparation, and the non-encapsulated mass using the 
following equation: 
EE%= mass (total) - mass (non-encapsulated) x 100                                          (5.5) 
                           mass (total) 
where mass (total) is the mass of the loaded core material (g), and mass (non-encapsulated) is the 
mass of the non-encapsulated core material (g). The masses of the non-encapsulated active 
principles were calculated from the formula (mass= V. C); where V is the volume of the 
microcapsules suspension and C is the concentration of the non-encapsulated core materials, 
obtained from the corresponding areas of the chromatograms that were quantified by the 
standard calibration curve. All measurements were done in triplicates. 
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5.2.4. Release studies 
In this chapter, three release studies are discussed. These studies examined the effects of varying 
some factors during the preparation of the microcapsules, and investigating the influence of these 
changes on the release behavior of vanillin and limonene. 
Release Study 1: Effect of changing the concentration of the wall materials 
Here we examined the effect of decreasing the concentration of chitosan and gum Arabic on the 
release rate of limonene from the microcapsules. Table 5.2 summarizes the preparation 
conditions for the two formulations A and B that were involved in this study.  
Table 5.2 The chemical composition of formulations A and B. 
 Formulation A Formulation B 
Emulsifier Tween
®
 20 Tween
®
 20 
Mass of emulsifier 2.58 g 2.58 g 
Limonene (Core) 32 g 32 g 
Chitosan 1 g 0.5 g 
Gum Arabic 2 g 1 g 
Hardening agent Sodium TPP (0.5 g) Sodium TPP (0.25 g) 
Release Study 2: Effect of changing the type of emulsifier on the release of limonene 
In this study, two different emulsifiers Span 85 and PGPR were used in the preparation of two 
formulations; C and D. Both emulsifiers were used in same amounts as shown in Table 5.3. 
Table 5.3 The chemical systems of formulations C and D. 
 Formulation C Formulation D 
Emulsifier Span 85 PGPR 
Mass of emulsifier 0.35 g 0.35 g 
Limonene (Core) 1 g 1 g 
Chitosan 0.5 g 0.5 g 
Gum Arabic 1 g 1 g 
Tannic acid 0.2 g/ 2 ml deionized water 0.2 g/ 2 ml deionized water 
 73 
 
Release Study 3: Effect of changing the type of the core material 
In this study vanillin was used as the encapsulated core material instead of limonene. As 
indicated in chapter 3, (section 3.2.1), vanillin crystals were first dissolved in corn oil to prepare 
the emulsion before initiating the complex coacervation process. Table 5.4 shows the chemical 
system in formulations E. This formulation is comparable to formulation D in the second release 
study, where limonene was encapsulated using the same emulsifier. 
Table 5.4 The chemical composition of formulation E. 
 Formulation E 
Emulsifier PGPR 
Mass of emulsifier 0.6 g 
Corn oil 4.5 g 
Vanillin (Core) 0.12 g 
Chitosan 0.5 g 
Gum Arabic 1 g 
Tannic acid 0.2 g/ 2 ml deionized water 
 
5.2.4.1. Cumulative release profiles  
The release studies of the active agents from the microcapsules were conducted directly after the 
preparation of each formulation. In each study, equal volumes of microcapsules suspensions 
were washed with deionized water and n-hexane (¾ of the volume of the microcapsules 
suspension) in order to remove all the non-encapsulated core material from the microcapsules 
surrounding phase, and then placed in a sealed glass container that contained a fresh 30 ml of 
hexane. Samples were incubated at a constant temperature (50ºC for the first release study and 
37ºC during the second and third release studies) and mild continuous stirring at 100 rpm, for a 
specific duration according to each study (7-40 days). At predetermined time intervals, samples 
were taken out of the incubating chamber; certain volume of hexane (2 ml) in the supernatant 
was filtered through 0.2 µm pore size polypropylene filter and placed in a sealed vial for GC-FID 
analysis.  The volume of each GC-FID injected sample was 0.1μL. Injections were carried out in 
triplicates and the mean value of the peak area corresponding to the active agent (either limonene 
or vanillin) in each acquired chromatogram was determined. The average areas were then 
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quantified to the corresponding concentration in view of the standard calibration curve of the 
core material being measured. Then the masses of the released active agents were calculated 
from the formula (mass= volume x concentration). The cumulative release from the 
microcapsules suspension for each time interval was calculated from the following equation:
14
 
Cumulative Release % (CR %) = Mx / M0  X 100                                     (5.6) 
Where Mx is the mass of released limonene or vanillin at a certain time interval and M0 is the 
initial mass of limonene or vanillin present in the microcapsules. 
5.2.4.2. Kinetic analysis of the release profiles 
The obtained cumulative release data were kinetically examined to determine the release order of 
limonene and vanillin from the microcapsules using Excel, Microsoft Office 2010. Four release 
kinetics models were used to assess and fit the obtained release profiles of limonene and vanillin 
microcapsules; the zero-order model, the first order model, the Higuchi model and the 
Korsmeyer-Pepppas model. Thereafter, upon comparison of the linear regressions of the four 
models for a given release profile,  the kinetic model with higher regression coefficient (r
2
) was 
considered as the most appropriate release kinetic model for that release profile. This method is 
frequently used in the literature to determine the kinetic model of the in-vitro drug release and 
active principles from different dosage systems, and nano- and microcapsules.
15-20
 
5.3. Results and discussion 
5.3.1 Optical Microscopy 
The morphology of the microcapsules of the three release studies has been examined by means 
of optical microscopy. Figures 5.2, 5.3 and 5.4 show the micrographic images of the 
microcapsules of the first, second and third release studies, respectively. It was observed that the 
microcapsules in all the formulations are spherical. Limonene microcapsules in formulations A 
and B of release study 1 are mononuclear and have a regular and smooth appearance. Images (a) 
and (b) in Figure 5.2 show that the microcapsules of formulation A have a larger size than those 
of formulation B (images (c) and (d) in Figure 5.2). The appearance of the limonene 
microcapsules in formulation D (images (c) and (d) in Figure 5.3) would suggest that they are 
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polynuclear in nature. The same morphology was also observed for the vanillin microcapsules in 
formulation E (images (a) and (b) in Figure 5.4). However, the apparent polynuclear vanillin 
microcapsules look denser than the limonene ones which were prepared using the same 
emulsifier; this might be due to the different nature, including the rheological properties and 
densities between limonene and corn oil (than was used to dissolve vanillin) which comprise the 
core of the microcapsules and also the relatively higher amount of vanillin and corn oil used than 
the limonene in formulation D. 
5.3.2 Particle Size Evaluation 
Particle size distributions in both, volume and number of the microcapsules of the release studies 
1, 2 and 3 are shown in Figures 5.5, 5.6, and 5.7, respectively.  The mean diameter values of the 
six formulations in the three studies are given in Table 5.5. 
For formulation A (Figure 5.5 (a)), a bimodal distribution was observed with a mean particle size 
around 8 μm. A bimodal distribution was also seen in the particle size distribution of formulation 
B (Figure 5.5 (c)), with a mean particle size of 3.8 μm. This shows that the particle size increased 
by doubling the concentration of the wall material in formulation A, and thus follows the same 
trend observed in previous reports in the literature
21,22
 where it was concluded that the size of the 
microcapsules prepared by the complex coacervation method increases by increasing the wall 
material concentration. 
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Figure 5.2 (a) and (b) Optical microscopy images of limonene microcapsules of formulation A, 
(c) and (d) of formulation B after hardening and centrifugation. Magnification of images: (a) 
400x; (b) 1000x; (c) 400x and (d) 1000x.  
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Figure 5.3 (a) and (b) Optical microscopy images of limonene microcapsules solution of 
formulation C (formed with Span 85), (c) and (d) of formulation D (forms with PGPR) after 
hardening and centrifugation. Magnification of images: (a) 400x; (b) 1000x; (c) 200x and (d) 
400x.   
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Figure 5.4 (a) and (b) Optical microscopy images of vanillin microcapsules of formulation E 
(with PGPR) after hardening and centrifugation. Magnification of images: (a) 100x and (b) 200x.   
The use of different emulsifiers in the second release study showed dissimilarities in particle size 
distributions, although the other chemical system and preparation conditions were the same 
within the study. It was observed that the emulsifier PGPR which was used in the preparation of 
formulations D has led to the formation of microcapsules not just with a different morphology, 
but also with a greater mean diameter than those obtained by the Span 85 emulsifier (formulation 
C). 
Table 5.5 Mean diameters of produced microcapsules. 
Release Study Formulation Volume mean diameter (µm) 
1 
A 8.0 
B 3.8 
2 
C 11.1 
D 18.4 
3 E 38.2 
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5.3.3. Scanning Electron Microscope  
The SEM micrographs of formulation B (Figure 5.9 (1) and (2)) show that the fabricated 
microcapsules have spherical shape and are covered with a thick layer. This might reveal that 
some of the wall materials could not deposit completely on the core material during the 
preparation process, but eventually deposited on the surface of the formed microcapsules later 
covering it with this layer. Similar images were observed by Yang et al., who reported that such 
“conglutination” in appearance is due to the use of high viscosity chitosan.23 
5.3.4. Encapsulation efficiency of microcapsules  
In general, the microencapsulation of hydrophobic materials by the complex coacervation 
method results in high encapsulation efficiency.
24
 Table 5.6 compares the percentage of the core 
material (limonene or vanillin) entrapped in the microcapsules in the six formulations. 
In the first release study, the difference in the EE% is related to the difference in the 
concentration of the wall material, while in the second and third release studies, the 
encapsulation efficiency was influenced by the type of the emulsifier used.  
Decreasing the concentration of the wall materials in formulation B to half the amount of 
formulation A resulted in the reduction of the EE% from 98.4% to 93.2%. It is worth noting that 
previous studies reported that encapsulation efficiency increases with increasing the 
concentration of the polymers. A possible explanation of this is that higher concentrations of the 
dispersion phase result in higher viscosity and enhance faster precipitation of the polymer on the 
oil phase, and thus delays its diffusion from the microcapsules to the outer phase.
25
 
In the encapsulation efficiencies of the second release study; formulations C (98.6%) and D 
(90.4%), it could be observed that changing the type of emulsifier had an influence on how much 
core material could be entrapped. This could also be related to the difference in the morphology 
of the formed microcapsules (mononuclear versus multinuclear). 
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(c) 
 
(d) 
Figure 5.6 Particle size distribution of limonene microcapsules of the first release study: 
formulation A; distribution in volume (a) and in number (b); and formulation B; distribution in 
volume (c) and in number (d). 
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(c) 
 
(d) 
Figure 5.7 Particle size distribution of limonene microcapsules of the second release study: 
formulation C; distribution in volume (a) and in number (b); and formulation D; distribution in 
volume (c) and in number (d) 
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(a) 
 
(b) 
Figure 5.8 Particle size distribution of vanillin microcapsules of the third release study: 
formulation E; distribution in volume (a) and in number (b). 
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Figure 5.9 SEM micrographs of limonene microcapsules of formulation B after freeze- drying. 
The effect of the emulsifier on the characterization properties of microcapsules is often 
mentioned in the literature. For example recently it was reported the effect of the HLB 
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(hydrophilic-lipophilic balance) of the surfactants Tween 20, Tween 80, Tergitol 15-S-9, Span 
85, and their combinations  on the encapsulation efficiency of thymol oil/PLA microcapsules 
prepared by simple coacervation.
25
 The HLB range of the emulsifiers used in that study was 
between 11 and 16.5 and the highest EE% obtained was 65 % when Tergitol 15-S-9 (HLB=13.3) 
was used. The influence of the HLB value on the encapsulation efficiency of microcapsules 
obtained by complex coacervation was investigated by Rabisková et al.,
26
 where they reported 
that emulsifiers of HLB values between 1.8 and 6.7 resulted in encapsulation efficiencies, while 
using an emulsifier with an HLB value of 9.6 caused a significant decrease in the amount of the 
encapsulated oil. Higher HLB values of 10 and 15 failed to incorporate the oil inside the 
microcapsules. This explains the high EE % obtained with the lipophilic surfactants PGPR 
(HLB= 2-4)
27
 and Span 85 (HLB=1.8).
26
  
Table 5.6 Encapsulation efficiencies percentages of the formulations used in the three release 
studies. 
 
 
5.3.5 Release Studies 
5.3.5.1. Effect of changing concentration of the wall materials  
The release profiles of microcapsules in formulations A and B were investigated throughout the 
course of 30 and 40 days, respectively. It was notable from the cumulative release graphs (Figure 
5.10 and 5.11) of both formulations that the release rate was very slow and prolonged, and did 
not follow the expected biphasic release behavior which is usually obtained from microcapsules 
produced by the complex coacervation method. In formulation A, approximately 0.61% of the 
total encapsulated limonene was released after incubating the microcapsules suspension for 30 
 
Formulation 
 
 
Core 
material 
Emulsifier 
Total 
mass 
(g) 
Non-
encapsulated 
mass (g) 
Encapsulated 
mass (g) 
EE% 
A 
B 
Limonene Tween 20 32.5 0.5 32 98.4 
Limonene Tween 20 32.5 2.18 30.32 93.0 
C 
D 
Limonene Span 85 1 0.014 0.986 98.6 
Limonene PGPR 1 0.096 0.904 90.4 
E Vanillin PGPR 0.12 0.0058 0.1142 95.2 
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days (at 50º C and 180 rpm). For formulation B, it was observed that a mass of only 0.443 g was 
released, which corresponds to 1.5% of the initial encapsulated mass of 30.32 g. 
This difference between the amounts of limonene released in the two formulations is attributed to 
the difference in the thickness of the microcapsules wall.  Lower concentration of wall materials 
results in decreasing the microcapsules membrane, making the diffusion of the core material 
easier and hence, gives higher release rate.
28
 Furthermore, the smaller particle size of the 
microcapsules of formulation B also contributed to the faster percentage release of the internal 
phase; the diffusional path length for the oil becomes smaller and the contact surface area 
between the microcapsules and the dissolution medium becomes larger.
29
 
 
Figure 5.10 Cumulative release profile of limonene in formulation A. 
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Figure 5.11 Cumulative release profile of limonene in formulation B. 
The release curves obtained from this study which demonstrated a very slow release behavior, 
along with the SEM images (Figure 5.9) suggest that the release of limonene was hindered by the 
layer that appeared to surround the microcapsules. This layer might be due to the high viscosity 
of chitosan as discussed earlier. It might be also due to the gelation caused by the hardening 
agent sodium TPP or due to excess limonene oil that might have leaked with time.  
5.3.5.2. Effect of the type of emulsifier on the release pattern of limonene 
The release manner of limonene from microcapsules in formulations C and D varied with the 
type of the emulsifier used in each formulation. Both formulations exhibited biphasic release 
behavior; one that is characterized initially by a burst release effect that is followed by a plateau 
of gradual sustained release.
30
 Nevertheless, the initial burst release effect took a longer time in 
formulation C (Figure 5.12) than in D (Figure 5.13). The burst release effect is described as a 
high initial delivery of the encapsulated active agent before the release profile reaches a steady 
rate.
23,30
 The reason of this fast initial release phase might be due to the distribution of some of 
the core material on the surface of microcapsules. Once this adsorbed surface oil is released, the 
release pattern becomes stable and the remaining oil is then liberated mainly by penetration 
through the microcapsules wall.
23,31
 The burst effect may also occur because of the low 
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molecular weight of the active agent and as a result of the high osmotic pressure and difference 
in concentration gradient.
30
 Although the initial burst effect might contribute to the reduction of 
the lifetime of the product, it is desired in specific applications, such as encapsulated flavors, 
wound treatment, targeted delivery (where a targeted burst release is required) and pulsatile 
release.
32
  
It has been previously reported that the multinuclear microcapsules have better controlled release 
behavior than the mononuclear microcapsules, which makes them more favorable in the 
applications that require prolonged release.
22
 By analyzing the curves of limonene release in our 
study, it could be observed that the release was initially faster in formulation D than in C. 
However, the stable sustained release phase started earlier (after almost 24 hours) in formulation 
D (Figure 5.13); whereby 43% of the incorporated limonene was released. The same phase 
started in formulation C (Figure 5.12) after 120 hours (5 days) where about 74% of the 
encapsulated limonene was released. It was notable that after incubating both formulations for 7 
days (168 hours), at 37 ºC and 100 rpm, the overall cumulative release for the mononuclear 
microcapsules was about 75%, whereas it was 52% for the polynuclear microcapsules. In this 
context, it could be concluded that the release rate is lower in the polynuclear microcapsules than 
in the case of mononuclear microcapsules. These results are in agreement with those described 
by Jégat et al.; who used different stirring speed to produce mononuclear and polynuclear 
microcapsules, and reported a lower release rate for the polynuclear microcapsules than the 
mononuclear microcapsules.
33
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Figure 5.12 Cumulative release profile of limonene in formulation C (with Span 85). 
 
Figure 5.13 Cumulative release profile of limonene in formulation D (PGPR). 
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5.3.5.3 Effect of the type of the core material 
This study was performed to investigate the release profile of vanillin from the chitosan/gum 
Arabic microcapsules (Formulation E) in which PGPR was used as the emulsifiers. It was found 
that there was a change in the morphology of vanillin microcapsules of formulation E after 10 
days of incubating the sample at 37ºC and stirring at 100 rpm to study the release. Figure 5.14 
shows the alteration that occurred to the appearance of the internal phase of the multinuclear 
microcapsules by the end of the study. There seemed to be a collapse/disintegration in the 
encapsulated core droplets inside the main membrane of each microcapsule. 
Figure 5.14 Optical microscope images of vanillin microcapsules of formulation E: (a) before 
and (b) after10 days after incubating at 37ºC ± 1 and 100 rpm during the third release study. 
It could be observed from the cumulative release profile of vanillin in formulation E that it also 
demonstrated a biphasic release pattern but is much prolonged than the limonene released from 
the polynuclear microcapsules in formulation D (prepared with the same emulsifier and have 
similar morphologies). The release plot (Figure 5.15) shows a high initial release followed by a 
plateau. However, in this formulation the plateau was attained after about 48 hours; whereby 
approximately only 16% of the total encapsulated vanillin was released. This result is relatively 
lower than what was observed in the case of the release profile of limonene in formulation D. 
Furthermore, it was observed that after 7 days (168 hours), the total cumulative % of vanillin 
released was about 19.4 % of the total amount of encapsulated vanillin, unlike limonene 
formulation D in which 52 % of the total encapsulated limonene was released within the first 7 
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days of incubating at the same conditions (37ºC and 100 rpm). This slower release rate behavior 
is probably due to the difference in the chemical structure of vanillin and limonene, and also 
their ability to diffuse through the wall polymers, added to that the fact that vanillin, unlike 
limonene, which was dissolved formerly in corn oil and shares the microcapsules core with it, 
this have might participated in the slow transport of vanillin out of the microcapsules shell.  The 
results obtained here are similar to the  slow and sustained release profile of vanillin that was 
reported by Dalmolin et al.,
34
 who used poly-lactic acid nanoparticles to encapsulate vanillin and 
obtained a biphasic slow pattern with 20% cumulative vanillin release after 120 hours. In the 
same study, the authors mentioned the importance of the biphasic release in pharmaceutical 
applications; where the initial burst effect is needed in reaching suitable plasma concentration 
and triggering the therapeutic onset, whilst the plateau phase is important in maintaining a stable 
drug concentration for long duration. Prolonged sustained release of vanillin aroma from 
polysaccharide polymeric hydrogels was also described in the literature as desirable in the 
perspective of controlled release applications.
35
 
 
Figure 5.15 Cumulative release profile of vanillin in formulation E (PGPR). 
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5.3.5.4 Kinetic analysis of the release profiles 
The data obtained from the former cumulative release profiles were fitted to the zero-order, the 
first-order, the square root of time (Higuchi) and the Korsmeyer-Peppas model equations to 
determine the kinetics and the mechanism of limonene and vanillin release from the 
microcapsules. Table 5.7 lists the regression coefficients (r
2
) and the diffusion exponent (n) of 
the determinations.  The release kinetic of formulation A suggests a zero-order release; since it 
has shown a higher r
2 
value than the other two models. However, it was found that the release 
data of formulations B and C could be best fitted into the first order release kinetics. The highest 
coefficient for the release data of formulations D and E (who have the same morphology) was 
observed for the Higuchi release, but it was also noticed that the values of regression coefficients 
of formulation D for all of the three models were relatively lower than the coefficients of 
formulations A, B, C and E. Probably the release data of formulation D would be better fitted in 
a different kinetic model.  
Table 5.7 Correlation Coefficient (r
2
) of release kinetics and diffusion exponent (n) of active 
agents from the chitosan/gum Arabic microcapsules. 
Formulation Zero Order (r
2
) First Order (r
2
) 
Higuchi 
(r
2
) 
Korsmeyer-Peppas (n) 
A 0.8903 0.8899 0.7233 ≈0.45 
B 0.9866 0.9869 0.9443 ≈0.59 
C 0.9260 0.9547 0.9250 ≈  0.78 
D 0.7828 0.8331 0.8697 ≈ 0.45 
E 0.8244 0.8401 0.9733 ≈ 0.09 (< 0.43) 
 
Despite the differences in their release profiles, the (n) value “release exponent” of the 
Korsmeyer–Peppas equation plot for the formulations A, B, C and D fell between (0.43 and 
0.85) which indicates that the mechanism of limonene release in these formulations most 
probably follows an anomalous transport pattern, one that is controlled by non-Fickian diffusion 
and involves a combination of the diffusion and erosion mechanisms.
36
 This is consistent with 
the fact that the diffusion of materials through polymers is not always controlled by the standard 
Fickian diffusion model.
37
 However, the release exponent value (n) for formulation E was found 
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to be about 0.09 (i.e., ≤ 0.43); which suggests that the release of vanillin from the microcapsules 
was controlled by diffusion. This value is similar for the one reported in the literature for the 
vanillin release form poly-lactic acid nanoparticles;
34
 and thus, the adopted controlling release 
mechanism might be related to the type and nature of the core material in this case, i.e., vanillin. 
5.4. Conclusion 
In this chapter, chitosan/gum Arabic limonene and vanillin microcapsules were prepared by the 
complex coacervation method. The encapsulation efficiency ranged between 90.4% and 100%. 
Optical microscopy confirmed the spherical shape of the microcapsules. However, the 
morphology and the particle size of the microcapsules varied remarkably according to the 
chemical system of each formulation. The mean diameter of microcapsules based on volume 
distribution ranged from 3.8 µm to 38 µm. Tween 20 and Span 85 emulsifiers produced 
mononuclear microcapsules, while PGPR gave rise to multinuclear ones. Notably, the release 
profiles of the active agents from the microcapsules have shown different release characteristics 
and were dependent on the concentration of the encapsulating polymers, the nature of the 
incorporated core material and the morphology of the microcapsules. Additionally, they 
demonstrated a considerable controlled release patterns that would make their use appropriate for 
many applications. 
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Chapter 6: Impregnation of Microcapsules on Textiles and Evaluation of the 
Antimicrobial Activity 
6.1. Introduction 
Developing innovative textiles with added-value properties is a production engineering challenge 
that enhances market competitiveness and growth.
1
 Microencapsulation introduces new durable 
properties to fabrics through the incorporation of active compounds with various functions, such 
as antimicrobials, dyes, phase change materials, insect repellents, flame retardants, thermo- and 
photo-chromatic finishes and fragrances. 
2,3
 
The process of fixing the microcapsules onto textile substrates is critical in ensuring durability, 
wash-ability and the effectiveness of the added value to the fabric. The commonly known 
industrial methods that are used to apply microcapsules to fabrics are the spraying, 
padding/curing, bath exhaustion and coating. The bath exhaustion method is commonly applied 
when a chemical reaction between the fabric and microcapsules is required.
4
 These adhesion 
methods involve the use of two main groups of binders; polymeric resins, which possess a film-
forming ability, and polyfunctional crosslinking agents. The first group includes polymers, such 
as carboxymethyl cellulose, silicon, acrylate resin, polyether polyurethane and polyvinyl acetate, 
while the second group includes the chemical cross-linkers, which can be subdivided into 
formaldehyde based cross-linkers, e.g., formaldehyde and glutaraldehyde, and non-formaldehyde 
based cross-linkers, such as polycarboxylic acids, such as citric acid, succinic acid and 1,2,3,4-
butanetetracarboxylic acid.
5,6
 
Although film-forming binders provide a three dimensional network that strongly adheres 
microcapsules to the fabric, they may hinder the release of the encapsulated active agent and 
reduce the aroma intensity of the fragrance microcapsules after adhesion on fabrics.
5,7
 Therefore, 
chemical grafting by means of one of the members of the second group is sometimes preferred. 
Grafting or crosslinking of microcapsules to cotton fabrics via polycarboxylic acids occurs 
covalently through an esterification reaction between the carboxylic groups of the cross-linker 
and hydroxyl groups of the cotton cellulose and/or the hydroxyl groups of the polymers of the 
shell of the microcapsules (-OH groups of chitosan and gum Arabic). Figure 6.1 and Figure 6.2 
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help illustrate this reaction which occurs in the presence of heat and a catalyst. 
5,8-10
 The reaction 
can also be aided by microwave radiation
11
and ultraviolet radiation.
12
 
 
Figure 6.1 The cross-linking reaction between chitosan and cellulose of cotton using citric acid. 
Adapted from Ref 12. 
Figure 6.2 Representation of the proposed grafting reaction of the produced microcapsules on 
cotton fabrics. Adapted from Ref 10.  
Recently, more attention has been directed towards the production of antibacterial functionalized 
textiles for medical and hygienic uses.
13,14
 Vanillin encapsulated in a polysulfone polymer and 
incorporated onto cotton fabrics was reported to provide the fabrics with durable aromatic 
properties and antibacterial activity against Staphylococcus aureus.
15
 Rodrigues and coworkers 
used interfacial polymerization technology to encapsulate limonene in polyurethane-urea 
microcapsules for the purpose of producing durable fragrant fabrics.
16
 Sundrarajan also reported 
the preparation of limonene/gum Arabic microcapsules by the coacervation method for 
antibacterial textile application using citric acid for the grafting reaction. 
14,17
 
This chapter describes the strategy employed to achieve the immobilization of the produced 
limonene and vanillin microcapsules on cotton fabrics by using green materials and processes. 
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The work aimed at overcoming the effect of extreme thermal treatment on microcapsules during 
the drying and curing steps; as the temperature of the linking reaction seemed to greatly 
influence the amount and morphology of the microcapsules grafted onto the fabrics. The main 
challenge encountered was in reaching a formulation to prepare microcapsules with sufficient 
strength to endure the fixation process and thus, maximize their deposition on the fabrics. The 
antimicrobial activity of both the free microcapsules (before grafting) and the functionalized 
fabrics was investigated respectively by means of the agar diffusion test and the standard test 
method under dynamic contact conditions. 
6.2. Materials and methods 
6.2.1. Materials 
Chitosan (Degree of deacetylation 88-95%) and gum Arabic were used as shell-forming 
materials, and were purchased from BioLog Biotechnologie Und Logistik (Germany), and Sigma 
Aldrich, respectively. Standard 100% cotton fabric was purchased from SDC Enterprises 
Limited, UK. Vanillin and limonene, which were separately used as core agents, were purchased 
from Sigma Aldrich. Citric acid, sodium hypophosphite and sodium phosphate monobasic 
monohydrate were purchased from Sigma Aldrich and were used in the chemical grafting 
reaction. Tween 20 and Span 85 were used as emulsifying agents and were supplied from Sigma 
Aldrich. Polyglycerol polyricinoleate (PGPR 4150), also used as emulsifier in some preparations, 
was a gift from Palsgaard
®
, Denmark. Pure corn oil was used in the preparation of microcapsules 
to dissolve vanillin, and was obtained from Sigma Aldrich. Sodium tripolyphosphate (TPP) 
(Sigma Aldrich) and tannic acid (Merck) were used individually as hardening agents in different 
preparations. N-hexane was used as the washing medium for the microcapsules and was supplied 
by Carlo Erba Reagents. Baypret USV
®
, a commercial polyurethane binder, supplied from 
Bayer, was also used to evaluate the textile impregnation with the produced microcapsules. 
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6.2.2. Microcapsules preparation 
Vanillin and limonene microcapsules were produced independently by the complex coacervation 
technique according to the general procedure described in Chapter 3 (Sections 3.2.1.1 and 
3.2.1.2) and Chapter 4 (Section 4.2.2). In order to reach an optimized microcapsules formulation 
that could be successfully adhered to cotton fabrics, several trials were conducted by altering the 
amount of the core material incorporated, type of the emulsifier, and the hardening agent used. 
The amounts and different types of materials used in each formulation are listed in Table 6.1 
Table 6.1 Used chemicals and formulations in the preparation of microcapsules. 
Formulation 
Core 
material 
Amount of 
core material 
C 
(g) 
GA 
(g) 
Emulsifier 
(g) 
Hardening 
agent 
1 
Vanillin 
 
0.3g/20ml 
corn oil 
2 8 
Tween 20 
2.58 g 
Sodium TPP 
Ratio TPP : 
Chitosan 
(1:2) 
2 
Vanillin 
 
0.3g/20ml 
corn oil 
0.5 1 
Tween 20 
3.9 g 
3* Limonene 32.5 g 1 2 
Tween 20 
3.9 g 
4 ** Limonene 1 g 0.5 1 PGPR 
(0.35 g) 
Tannic acid 
0.2 g/ 2ml 
H2O (10%) 
5  Limonene 4.5 0.5 1 PGPR 
(0.6 g) 
6 ** Limonene 1 g 0.5 1 Span 85 
(0.35 g) 
7  Vanillin 0.02g/ 1 g 
corn oil 
0.5 1 PGPR (0.35 
g) 
8 *** Vanillin 0.12g/4.5 
corn oil 
0.5 1 PGPR  
(0.6 g) 
9  Vanillin 0.02g/ 1 g 
corn oil 
0.5 1 Span 85 
(0.35 g) 
*Limonene formulation 3 is formulation A that was investigated in the first release study in 
chapter 5. 
**Limonene formulations 4 and 6 are formulations D and C which were investigated in the 
second release study in chapter 5. 
***Vanillin formulation 8 is formulation E which was investigated in the third release study in 
chapter 5.
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6.2.3. Fabric treatment with microcapsules 
6.2.3.1. Simple coating  
This method was discussed in chapter 3, section (3.2.4.1). It involves immersing the cotton 
fabrics in a suspension containing the microcapsules without the addition of binders or grafting 
agents. 
 6.2.3.2. Fixation with binder 
The method applied was described by Rodrigues et al.
16
 for the fixation of polyurethane-urea 
microcapsules on wool/polyester fabrics at a laboratory scale while simulating the industrial 
impregnation conditions. An impregnation bath was prepared as shown in Table 6.2. The cotton 
fabrics were immersed in the bath and left for three minutes to allow for the penetration of the 
microcapsules and other bath constituents. The treated fabrics were passed through a two rollers 
foulard at a pressure of 3 bars and a speed of 3m/minute to squeeze the excess liquid from the 
fabric samples. The samples were then dried and cured thermally at the temperatures and time 
durations specified in Table 6.2.   
Table 6.2 Impregnation conditions with polymeric binder. 
Textile type Cotton lawn fabric 
Bath Volume 250 ml 
Bath Ingredients 
Microcapsules (formulation 1 and 2) 50 g/L 
Baypret
®
 USV (polyurethane binder) 50 g/L 
Perisoftal
® 
Nano (softener) 10 g/L 
Padding by Foulard 3 bar (0.3 MPa) 
Drying “Thermofixation” 100ºC-3 minutes 
Curing 140ºC -3 minutes 
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6.2.3.3. Fixation using citric acid 
Citric acid was used as a polycarboxylic acid cross-linker to covalently join the wall materials of 
the microcapsules (chitosan and gum Arabic) to the cotton fabrics by ester bonds. The procedure 
applied here is based on methods previously reported in the literature,
9,10,18
 but with some 
modifications. Briefly, the test fabrics were firstly immersed in a bath containing the 10 % w/v 
microcapsules suspension, 3% w/v citric acid, 1.5 % w/v catalyst (sodium phosphate monobasic 
monohydrate ) and thereafter heated at 50ºC for 5 minutes. Fabrics were then washed thoroughly 
with deionized water and passed through a 2 roller foulard with 1 bar pressure at a speed of 3 
m/min. Subsequently, fixation was achieved by placing the fabric samples in a thermofixation 
chamber with circulating air at a temperature of 90ºC for 2 minutes. After drying, the curing 
process was investigated at two different temperatures (120ºC and 150ºC for three and two 
minutes, respectively) to obtain the maximum number of microcapsules immobilized onto the 
fabrics. Table 6.3 summarizes the curing process conditions of different fabric samples. The 
fixation reaction was also investigated for samples 5 and 8 using a domestic microwave oven 
(MS-2029UW, LG), with an output of 800 Watts for one minute. The wet pick up percentage of 
the impregnated samples ranged between 95% and 100% and was determined after passing 
through the foulard by the following formula: 
16
 
Wet pick %= mass of impregnation bath taken by the fabric x 100                              (6.1) 
                                mass of the dry fabric 
Table 6.3 Curing conditions of microcapsules fixation using citric acid as a cross-linker. 
Formulation 3 4 5 5 6 7 7 8 9 
Curing temp 
(ºC) 
120 120 120 150 120 120 150 120 120 
Curing time 
(minutes)  
3 3 3 2 3 3 2 3 3 
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6.2.4. Characterization  
6.2.4.1. Optical microscopy 
The morphology of the microcapsules was analyzed by using a Leica DM 2000 optical 
microscope, working in transmission light mode, and equipped with a Leica Application Suite 
Interactive Measurement imaging software. Optical microscopy was also used to examine the 
impregnated fabrics prior to their examination with SEM. 
6.2.4.2. Particle size analysis 
The mean particle size and size distribution of the microcapsules suspensions were determined 
by means of a Beckman Coulter Laser Diffraction Particle Size Analyzer LS 230. 
6.2.4.3. Gas chromatography (GC-FID) 
GC-FID was used to determine the encapsulation efficiency of vanillin and limonene 
microcapsules. The method was previously reported in Chapter 3 (Section 3.2.2.4). The 
encapsulation efficiency (EE %) was determined based on the difference between the total mass 
of the core material initially used for each preparation, and the non-encapsulated mass, 
calculated according to the following formula: 
EE%= mass (total) - mass (non-encapsulated) x 100                                                    (6.1) 
                      mass (total) 
                                                                                          
where mass (total) is the mass of the loaded core material (g), and mass (non-encapsulated) is the 
mass of the non-encapsulated core material (g). The masses of the non-encapsulated active 
principles were calculated from the formula (mass= volume x concentration). The concentration 
of the non-encapsulated core materials were obtained from the corresponding areas under the 
curves of the respective chromatograms. 
6.2.4.4. Effect of heat on the morphology of microcapsules 
A simple test was done to examine the effect of temperature on the morphology of microcapsules 
prior to their chemical grafting onto fabrics. A sample of about one gram of each formulation 
was placed on a watch glass and introduced in an oven where they were exposed consecutively 
 105 
 
to temperatures of 50ºC, 120ºC, and 160ºC for 5, 2 and 2 minutes, respectively. Dry samples 
were then dispersed in deionized water and examined with the optical microscope to investigate 
possible deterioration in microcapsules’ morphology. 
6.2.4.5. Scanning electron microscope (SEM) 
A high-resolution (Schottky) Environmental Scanning Electron Microscope with X-Ray 
Microanalysis and Electron Backscattered Diffraction Analysis: Quanta 400 FEG ESEM/EDAX 
Genesis X4M operating at 15.00 kV was used to examine the morphological features of the 
microcapsules grafted onto the cotton fabrics. 
6.2.4.6. Solid Content Determination 
The solid content of the microcapsules was determined according to the European Standard EN 
827 method- “Determination of solid content in water based adhesives”. The steps of the test 
were previously discussed in detail in Chapter 3, Section 3.2.2.6. 
6.2.4.7. Effect of washing on treated fabrics 
In order to investigate the effect of washing on the grafted microcapsules and their antibacterial 
activity, after drying and curing, some fabric samples were washed with deionized water 
containing 2% commercial soap for 15 minutes at 40ºC, rinsed in deionized water, and then 
washed with 0.1N acetic acid and re-rinsed with deionized water. Acetic acid was used to 
remove any residual unreacted chitosan from the surface of the fabrics. The washing was done 
according to methods described in the literature;
19,20
 and was repeated three times to remove any 
excess of polymer (chitosan or gum Arabic) and any unattached microcapsules. 
6.2.4.8. FTIR spectroscopy 
FTIR spectroscopic assay was used to examine the grafting reaction of the microcapsules on the 
cotton fabric.  FTIR spectra were collected for the freeze-dried microcapsules, tannic acid, citric 
acid, control (untreated) cotton fabric, and the impregnated cotton fabric. The microcapsules 
were separated from the original microcapsule suspension by decantation and then freeze-dried 
into a powder form prior to the analysis. The analysis was conducted using a Jasco FT/IR-6800 
spectrometer, (Jasco Analytical Instruments, USA), equipped with a MIRacle™ Single 
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Reflection ATR (attenuated total reflectance ZnSe crystal plate) accessory (PIKE Technologies, 
USA) and a TGS (triglycine sulfate) detector. Cosine apodization function was used to suppress 
leakage side lobes on the sampled signal. FTIR spectra of 56 scans at a resolution of 4 cm
−1
 were 
collected and averaged to obtain the single-beam background and sample ATR spectra. The 
spectra were collected over the spectral range of 4000–500 cm-1 in the Absorbance mode. The 
fabrics were used as they are and certain parts were randomly sampled to ensure consistent 
analysis and reproducibility. Aliquots of powdered samples (citric acid, tannic acid and limonene 
microcapsules) were analyzed without dilution to obtain the corresponding analyte standard 
FTIR spectrum using the same ATR accessory. 
6.2.5. Evaluation of antibacterial activity 
6.2.5.1. Agar diffusion method 
This assay was conducted with the limonene and vanillin microcapsules suspensions obtained 
from formulations 4 to 9, after washing the microcapsules suspensions with deionized water and 
hexane to remove any excess oil or unreacted substances. Staphylococcus aureus (ATCC 19213) 
and Escherichia coli (ATCC 10536) were used as the test microorganisms, as representatives for 
Gram positive and Gram negative bacteria, respectively. The bacterial inoculums were prepared 
by transferring 4 isolated colonies of each type, under aseptic conditions, to separate test tubes 
containing nutrient broth that were then incubated at 37ºC for 24 hours. The inoculums were then 
diluted by sterilized Ringer solution to a concentration of 0.5 McFarland turbidity, which is 
comparable to a bacterial concentration of 1.5–3.0 x 108 CFU/ ml. The concentration of the 
bacteria dilutions were also ascertained through UV spectrophotometry by measuring the 
absorbance at a wavelength of 625 nm. The absorbance of S. aureus was 0.0938, while E. coli 
was 0.0940. The bacterial solutions were then inoculated on the surface of Mueller Hinton Agar 
plates, using sterilized cotton swabs, and the plates were allowed to dry. Then, a well of 6 mm 
diameter was made in the center of each inoculated plate; the plug was removed, and filled with 
100 µl of microcapsules suspension. 
The free active agents were also tested separately (not incorporated in microcapsules). The 
limonene oil was diluted in dimethyl sulfoxide (DMSO) (7:3 ratio), and the vanillin was 
dissolved in corn oil (0.03 g vanillin in 1g of oil). The plates were incubated at 37ºC for 24 h. 
 107 
 
After this period, the diameter of the inhibition zone was measured and incubation maintained 
for more 4 days in order to evaluate the possible change in the inhibition zone. The clear zone of 
inhibition formed around each hole after the incubation (inhibition halo), indicates an 
antimicrobial activity and its diameter is an indication of the inhibitory effect. All of the tests 
were done in duplicates. 
6.2.5.2. Standard test method under dynamic contact conditions 
This test was performed to evaluate the antibacterial activity of the fabrics impregnated with 
vanillin and limonene microcapsules. It is based on the American Society for Testing and 
Materials standard (ASTM) Designation: E 2149-01 standard method, with a slight modification. 
This standard method is originally designed to investigate the ability of samples treated with 
non-leaching (substrate-bound) antimicrobial agents to resist the growth of microbes under 
dynamic contact conditions.
21
  
In this work the bacterial inoculum was adjusted to 0.5 McFarland turbidity standard (which 
corresponds to a concentration of 1.5–3.0 x 108 CFU/mL) using sterilized Ringer solution. The 
concentration of the bacteria dilutions were measured spectrophotometrically by determining the 
absorbance at 625 nm. This solution was then diluted in a sterile buffer of 0.3 mM KH2PO4 (pH 
= 7.2 ± 0.1) to reach a concentration of 1.5-3.0 x10
5 
CFU/ml, and used as the working bacterial 
dilution employed in the assays. For the determination of bacterial inhibition, a fabric sample 
impregnated with the microcapsules with dimensions of 2 cm x 2 cm was introduced to 50 ml of 
the working bacterial dilution placed in a sterile 250 ml flask. The flask was then capped and 
placed in an orbital stirring bath at 37ºC. After one minute of stirring, 1 ml of the solution was 
aseptically collected to determine bacterial concentration by the standard plate counting 
technique; which involves using serial dilutions and incorporation in Petri dishes with nutrient 
agar.  
The obtained value was considered as the bacteria concentration at the initial contact time, t0. 
After taking the sample, the flask was returned to the bath immediately and stirred for a further 
15 minutes. Then, a new sample of the solution was aseptically collected for bacteria counting. 
The results of colony counting were converted to colony forming units per milliliter (CFU/ml) 
and used to calculate the percentage of bacterial reduction. Two other flasks, one containing 
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untreated fabric sample (without microcapsules), and another flask containing only the working 
bacterial dilution (without sample addition), both submitted to the same procedure of colony 
counting and percentage of bacteria reduction determination, were used as control.   
After the first 15 minutes of testing, the inoculum solution of the treated fabric samples and the 
blank control was renewed and the sampling was repeated for bacteria counting at 30, 45, 60, 75, 
90, 105 and 120 minute time periods. Each time before renewing the inoculum solution of the 
fabric sample, the sample was washed thoroughly with sterile deionized water before being 
introduced into the fresh inoculum solution. It is noteworthy to mention that the step of the 
inoculum renovation (every 15 minutes) is a modification of the original E 2149-01 standard 
method, and was introduced by Fernandes et al.,
22
 to evaluate the effective antibacterial activity 
for immobilized antimicrobials on leather coatings. Using a fresh bacterial inoculum at given 
specific contact times gives a better idea about the real amount of inhibition after that time of 
exposure.
22
 The percent of bacterial reduction upon contact with the fabric samples was 
calculated using the following equation:
21
 
Reduction (%) = (A−B∕A) × 100                                                                                      (6.2)                                     
where B is the CFU/ml for the flask containing the treated fabric sample after the specified 
contact time and A is the CFU/ml for the flask containing the inoculum before the addition of the 
treated fabric. 
6.3. Results and discussion 
6.3.1. Characterization of the produced microcapsules 
6.3.1.1. Optical microscopy 
The micrographs of the optical microscopy revealed that all the microcapsules were spherical in 
shape. The images of formulations 4, 6 and 8 were included in the preceding chapter, section 
(5.3.1), with sample codes D, C and F, respectively. The optical microscope images of 
formulations 1, 2, 3, 5, 7 and 9 are shown in Figure 6.3, 6.4, 6.5, 6.6, 6.7 and 6.8, respectively.  
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Figure 6.3 Optical microscope images of formulation 1. Magnification: a) 400 x and b) 1000 x. 
 
Figure 6.4 Optical microscope images of formulation 2. Magnification: a) 400 x and b) 1000 x. 
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Figure 6.5 Optical microscope images of limonene microcapsules of formulation 3. 
Magnification: a) 400 x and b) 1000 x.  
6.3.1.2. Particle size evaluation 
The differential and cumulative particle size distribution (relative to both the total volume and 
number of the microcapsules) of the nine formulations was investigated using laser particle size 
analyzer. The mean size of the microcapsules of the 9 formulations is shown in Table 6.4. 
As it was mentioned in the previous chapters, the type of the emulsifier has an influence on the 
size of the produced microcapsules. It can be observed that the use of the emulsifier Tween 20 
with sodium tripolyphosphate as hardening agent, resulted in the production of microcapsules 
with the smallest mean diameters, regardless of the amount of the oil or wall material used. It 
could be also noticed that for the same amount and type of core material; limonene formulations 
4 and 6, and vanillin formulations 7 and 9, PGPR emulsifier produced microcapsules with larger 
average size than Span 85. 
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Figure 6.6 Optical microscope images of limonene microcapsules of formulation 5; produced by 
PGPR emulsifier. Magnification: a) 100 x and b) 200 x. 
 
Figure 6.7 Optical microscope images of vanillin microcapsules of formulation 7; (a) after 
hardening (b) before hardening. Magnification: a) 200 x and b) 400 x. 
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Figure 6.8 Optical microscope images of vanillin microcapsules of formulation 9 produced by 
Span 85 emulsifier. Magnification: a) 400 x and b) 1000 x. 
Table 6.4 Mean diameters per volume of microcapsules, EE %, solid content % and the 
emulsifier used in each formulation. 
Formulation Type of Emulsifier 
Mean particle size 
diameter 
 (µm) 
EE% 
Solid 
Content 
% 
1 Tween 20 11.2 64.2% 6.1 
2 Tween 20 3.9 92.3% 24.9 
3 Tween 20 8.0 98.4% 20.4 
4 PGPR 18.4 90.4% 27.8 
5 PGPR 39.0 94.1% 28.8 
6 Span 85 11.1 98.6% 25.3 
7 PGPR 15.7 95.7% 28.3 
8 PGPR 38.3 98.3% 29.7 
9 Span 85 10.4 100 % 25.4 
The size distribution charts for all the studied formulations are included in the Appendix of this 
chapter, except for formulations 3, 4, 8 and 6 which were formerly presented in chapter 5. 
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6.3.1.3. Encapsulation efficiency of microcapsules 
The percentage of the encapsulated core material in each formulation is reported in Table 6.4.  
The vales of EE% ranged from 64.2% to100%. This variation was discussed before in detail in 
chapter 4. 
6.3.1.4. Effect of heat on the morphology of microcapsules 
Limonene microcapsules resulting from formulations 3, 4, 5 and 6 were all subjected to 
temperatures of 50ºC, 120ºC, and 160ºC for 5, 2 and 2 minutes, respectively. The optical 
microscope images of the remaining microcapsules (microcapsules not destroyed during the 
heating process) revealed that the highest decline in the number of the microcapsules was 
observed for formulations 3 and 5 (Figure 6.9 (a) and (c)). It was also observed that the 
multinuclear microcapsules of formulation 5 maintained their morphology in spite of their 
decreased number, unlike the microcapsules of formulation 4 which did not retain the 
multinuclear morphology after the thermal treatment but did not show significant decrease in 
number. This may be due to the higher amount of the emulsifier PGPR and limonene in 
formulation 5, in comparison with formulation 4, helped the microcapsules to maintain their 
original structural features. 
6.3.1.5. Solid content 
The solid content of the formulations was determined prior to the grafting process and without 
washing the microcapsules according to the procedure described in chapter 3 (Section 3.2.2.6). 
The values extended from 6.1% to 29.7% as shown in Table 4. It was found that the 
microcapsules prepared with tannic acid as the hardening agent had higher solid content % than 
the ones hardened with sodium tripolyphosphate. Furthermore, it was noticed that microcapsules 
prepared with the emulsifier PGPR and hardened with tannic acid had a higher solid content % 
than those produced with Span 85, using the same hardening agent. 
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6.3.2. Characterization of the treated fabrics  
6.3.2.1. Simple coating method 
In this procedure the microcapsules were not chemically fixed onto the fabrics, but rather applied 
by immersing the fabric in the microcapsules suspension and allowing it to be air-dried. These 
physically attached microcapsules would not be retained if the fabric is washed.
19
 However, this 
method might be suitable for disposable fabrics, such as surgical clothing and gowns and some 
other healthcare textiles that would not need to be washed and thus, no chemical reaction is 
needed to fix the microcapsules onto the fabric. SEM images of the surface of cotton fabrics 
treated with vanillin microcapsules of formulation 1 by this method are shown in Figure 6.10. 
The SEM images reveal that the deposited microcapsules have spherical shape and rough surface 
and were found mostly in aggregates positioned in the spaces present between the fabric fibers. 
 
Figure 6.9 Optical microscope images of limonene microcapsules, after exposure to 
temperatures of 50ºC, 120ºC, and 160º C for 5, 2, and 2 minutes, successively. (a) Formulation 3, 
(b) Formulation 4, (c) Formulation 5 and (d) Formulation 6. 
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Figure 6.10 SEM images of cotton fabrics with vanillin microcapsules of formulation 1 applied 
with simple coating method. 
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The elemental analysis of the wall material composition of the vanillin microcapsules deposited 
on the fabrics with quantification is presented in Figure 6.11. The presence of carbon, nitrogen 
and oxygen with percentages similar to the originally present in the structure of gum Arabic and 
chitosan was detected, which confirms the presence of both polymers in the shell of the 
microcapsules. 
 
Figure 6.11 Results of the elemental analysis of the wall material composition of the 
microcapsules on the treated fabrics (obtained by SEM). 
6.3.2.2. Fixation of microcapsules with Baypret USV
®
 binder 
Baypret USV
®
 is a polymeric binder based on polyether polyurethane that is frequently used to 
immobilize the microcapsules on the fabrics. It could be observed from the SEM images (Figure 
6.12) of the fabrics impregnated with vanillin microcapsules of formulations 1 and 2 by using 
this polymeric binder that the morphological features of the microcapsules were significantly 
vanished becoming completely covered with a thick film of the binder. The drawbacks of using 
polymeric binders, as reported in the literature, include the change of the textiles properties, such 
as the decrease of the air permeability and breathability, softness, increased fabric drape, and 
change in the tensile strength.
23
 
However, the use of polyurethane binders to successfully bind microcapsules to textiles 
substrates has been reported, such as the example of polyurethane-urea microcapsules
1,16
 and 
melamine–formaldehyde microcapsules.23 Since it has been also reported that the fixation of the 
microcapsules with a polymeric binder depends on the chemical nature of the microcapsules, as 
well as the textile substrates,
23
 in this context, we can conclude that polyurethane binder is most 
likely inadequate to be used with the microcapsules wall materials and/or the fabric used in this 
study. 
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Figure 6.12 SEM micrographs of cotton fabrics impregnated with vanillin microcapsules and 
Baypret USV
®
 binder:  (a) Formulation 1 (b) Formulation 2 (c) Control fabric.   
(a) 
(c)  
(b) 
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6.3.2.3. Grafting with citric acid and thermofixation 
Cotton fabrics impregnated with microcapsules of different formulations and grafted thermally 
with citric acid were examined with SEM. It was observed that only small amount of the 
limonene microcapsules of formulation 3, the one prepared with Tween 20 emulsifier and 
hardened with sodium tripolyphosphate could be grafted onto the fabrics by drying at 90ºC for 2 
min and curing at 120ºC for 3 min (Figure 6.13). The grafted microcapsules of this formulation 
were spherical in shape and some had a noticeable rough surface. A very similar observation was 
reported by Butstraen et al.,
24
 who encapsulated Miglyol by chitosan and gum Arabic using 
sodium tripolyphosphate as the hardening agent. Butstraen et al reported that the rough surface 
of the shell consisted of smaller coacervated particles. Apparently, this rough surface is a result 
of using sodium tripolyphosphate as the hardening agent; since the surface of the microcapsules 
has become smooth when tannic acid was used to harden the microcapsules instead of sodium 
tripolyphosphate, as presented in the succeeding sections. The small number of grafted 
microcapsules could be due to the thermal instability of the microcapsules and their inability to 
tolerate the high temperature of the treatment. 
Fabrics impregnated with formulations 6 and 9 that were produced with Span 85 emulsifier did 
not have any attached microcapsules after the drying and curing step. However, some remnants 
of the microcapsules could be observed in spaces between the fabric fibers as shown in Figure 
6.14. This suggests that the formulations obtained from Span 85 emulsifier could not survive the 
conditions of the thermofixation and curing at 120ºC. 
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Figure 6.13 Limonene microcapsules of formulation 3 grafted on cotton fabrics by chemical 
grafting method followed by drying at 90ºC and curing at 120ºC. Grafting was done by citric 
acid and sodium phosphate monobasic monohydrate as a catalyst. 
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Figure 6.14 SEM images of fabrics impregnated with (a) limonene microcapsules of formulation 
6 and (b) vanillin microcapsules of formulation 9. Both formulations could not sustain the 
treatment and remnants of microcapsules could be observed. 
(a) 
(b) 
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SEM images of the fabrics treated with limonene and vanillin microcapsules obtained from 
formulations 4 and 7 are shown in Figure 6.15 and 6.16, respectively. Despite the fact that the 
two formulations were prepared with the same amounts of PGPR emulsifier (0.35 g) and the 
hardening agent tannic acid, and undergone the same conditions of drying at 90ºC and curing at 
120ºC, it could be observed that higher number of vanillin microcapsules could be grafted 
(Figure 6.16) than the limonene ones (Figure 6.15). This suggests that the type of the core 
material may have an influence on the stability and thus, on the amount of the grafted 
microcapsules; since the two formulations experienced the same conditions during the 
preparation and grafting and contained the same amounts and types of all the ingredients, except 
for the encapsulated core. Taking into consideration that the vanillin was dissolved in corn oil, it 
might have helped in keeping the integrity of the microcapsules during the treatment more than 
the other formulation in which the core phase was limonene itself. 
It was also observed that the grafted microcapsules in the both formulations seemed to be 
covered with a thin film-like layer. This film was considerably less evident when the curing 
temperature was elevated to 150ºC for 2 minutes. SEM micrographs of grafted vanillin 
microcapsules of formulation 7 (Figure 6.17) show that the microcapsules have become more 
visible than the grafted vanillin microcapsules (Figure 6.16) after raising the curing temperature 
of the samples to 150ºC. 
The highest amount of microcapsules that was successfully grafted onto the fabrics resulted from 
the limonene microcapsules of formulation 5 (Figure 6.18 and 6.19) and vanillin microcapsules 
of formulation 8 (Figure 6.20) using a curing temperature of 120ºC for 3 minutes.  This is 
probably because of their relatively higher solid content (w/w %) when compared with the other 
formulations, as shown in Table 6.4 (Formulation 5= 28.8%; Formulation 8= 29.7%). Perhaps 
the high amount of PGPR and the presence of tannic acid as the hardening agent resulted in 
improved thermal stability of the microcapsules during the thermofixation and curing steps. It 
was also noticed that the increasing of the amount of emulsifier to 0.6 g, together with increasing 
the amount of core (limonene oil and vanillin dissolved in corn oil) made the limonene 
formulation endure the treatment better than the one with vanillin; on the contrary to what was 
observed previously in formulations 4 and 7 with lower core and emulsifier amounts, where the 
vanillin formulation was more stable than that with limonene. The impact was obvious in the 
 122 
 
amount and distribution of the fixed microcapsules. The film that covered the microcapsules in 
the previous formulations did not appear in this case, revealing the smooth appearance of the 
microcapsules surface, although the curing was performed at the same temperature.   
 Compared with the mean average size of microcapsules in both formulation 5 and 8 (39.0µm 
and 38.3µm, respectively), it was observed that only microcapsules of smaller diameter could be 
grafted and retained on the textiles after curing. This is perhaps due to the removal of the bigger 
microcapsules in the washing step that was performed directly after the reaction with citric acid 
and before the thermofixation process. Monllor et al. reported a similar observation and 
concluded that the smaller microcapsules tend to remain on the fabrics after several washing 
cycles, whereas the larger ones are usually lost faster.
25
  
Interestingly, the optical microscope images of fabrics impregnated with these two formulations 
indicated that the microcapsules seemingly kept their polynuclear morphology of their internal 
phase after the thermal fixation and curing reaction at 120ºC (Figure 6.21). 
Figure 6.22 shows that increasing the curing temperature applied to limonene microcapsules of 
formulation 5 to 150ºC resulted in lowering the number of the grafted limonene microcapsules. 
Accordingly, it can be concluded that curing at 120ºC for 3 minutes was more favorable for this 
formulation. 
6.3.2.4. Effect of washing  
SEM images of fabrics impregnated with limonene microcapsules of formulation 5 that was 
subjected to a washing process with commercial soap and acid, process repeated for three times 
according to the method described previously in Section 6.2.4.4, are shown in Figure 6.23. It can 
be seen that the acidic washing solution affected the appearance of the fabrics; nevertheless, it 
showed that the microcapsules are still firmly attached onto them. 
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Figure 6.15 SEM images of fabrics impregnated with limonene microcapsules of formulation 4 
cured at 120ºC. 
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Figure 6.16 SEM images of fabrics impregnated with vanillin microcapsules of formulation 7 
cured at 120ºC for 3 minutes. 
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Figure 6.17 SEM images of fabrics impregnated with vanillin microcapsules of formulation 7 
cured at 150ºC for 2 minutes. 
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Figure 6.18 SEM images of fabrics impregnated with limonene microcapsules of formulation 5 
cured at 120ºC for 3 minutes. 
 127 
 
 
Figure 6.19 SEM images of fabrics impregnated with limonene microcapsules of formulation 5 
cured at 120ºC for 3 minutes. 
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Figure 6.20 Vanillin microcapsules of formulation 8 grafted on cotton fabrics by chemical 
grafting method followed by thermal drying and curing at 120ºC for 3 minutes.  
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Figure 6.21 Optical microscope images of (a) limonene microcapsules of formulation 5 and (b) 
vanillin microcapsules of formulation 8, grafted on cotton fabrics by chemical grafting method 
followed by thermal drying and curing at 120ºC for 3 minutes. 
6.3.2.5. Fixation with citric acid and microwave 
Using the microwave technology to adhere and cure the microcapsules seemed to be destructive, 
since the SEM images of fabrics impregnated with formulation 5 and 8 and treated with the 
microwave for one minute showed almost no microcapsules except few scattered ones which are 
oval in shape (Figure 6.24). This perhaps suggests that the curing time or/and the microwave 
power level should have been decreased to avoid the loss of the microcapsules or that this 
method is not suitable for these formulations.    
(a) (b) 
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Figure 6.22 SEM images of fabrics impregnated with limonene microcapsules of formulation 5 
cured at 150ºC for 2 minutes. 
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Figure 6.23 SEM micrographs of cotton fabrics impregnated with limonene microcapsules 
(formulation 5) after being washed with 2% commercial soap and 0.1N acetic acid. 
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Figure 6.24 SEM images of fabrics impregnated with (a) limonene microcapsules of formulation 
5 and (b) vanillin microcapsules of formulation 8; both cured using a home-use microwave. 
6.3.2.6. FTIR Spectra  
The FTIR spectra of tannic acid (the hardening agent), the freeze-dried limonene microcapsules 
(formulation 5), citric acid (the cross-linker), control cotton fabric, and the treated cotton fabric 
(with formulation 5, cured at 120ºC for 3 minutes) are shown in Figure 6.25. The FTIR spectrum 
of tannic acid (Figure 6.25.A) showed a broad band from about 3000 cm
-1
 to 3350 cm
-1
 centered 
at 3326 cm
-1
; which represents the stretching vibrations of –OH groups in the phenolic structure 
of tannic acid.
26
 The two sharp peaks present at 1698 cm
-1
 and 1607 cm
-1
 can be assigned to the 
C=O group stretching and the aromatic C-O stretching vibrations, respectively. Similar 
characteristic sharp peaks for tannic acid are reported at 1713 cm
-1
and 1613 cm
-1
 in the 
literature.
26,27
  
The spectrum of the chitosan/gum Arabic microcapsules loaded with limonene (Figure 6.25.B) 
showed the presence of an important peak at 2855 cm
-1
. This same peak was reported in the 
literature as an indication of the occurrence of complex coacervation between chitosan and gum 
Arabic; and it was also reported that such peak does not appear in the individual FTIR spectra of 
chitosan and gum Arabic.
28
 Additionally, the broad band at about 3300 cm
-1
 is attributed to the –
OH groups of both chitosan and gum Arabic along with the overlapping stretching band of the –
NH of chitosan. This band can also represent the hydrogen bonds established between gum 
Arabic and chitosan.
24
 It can also reflect the hydrogen bonding with tannic acid that was used as 
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the hardening agent; as a similar broad band was seen in its individual spectrum as previously 
mentioned. The peak that appears at 1731 cm
-1
 indicates the chemical combination between 
chitosan and gum Arabic that formed the shell of the microcapsules; since a similar peak (at 
1720 cm
-1
) was reported by Yang et al.
28
 The peak appearing at 2924 cm
-1
 is due to C-H 
stretching vibration, while the one present at 1610 cm
-1
 is related to chitosan structure and 
represents –NH angular deformation.24  
The spectrum of citric acid (Figure 6.25.C) has shown peaks of stretching vibrations absorption 
of –OH groups at about 3492 cm-1 and 3280 cm-1. The two peaks of strong intensity which 
appeared at 1742 cm
-1
 and 1693 cm
-1
 represent the characteristic stretching C=O of the -COOH 
group of acids. These values are very close to those reported by Yang et al.
10
 
The FTIR spectrum of the untreated (control) cotton fabric sample (Figure 6.25.D) has shown 
peaks at 3332 cm
-1
, 2899 cm
-1
 and 1029 cm
-1 
that correspond to the stretching vibrations of the 
groups –OH, -CH and –C-O-C- present in the cellulosic structure of cotton, respectively.10,19  
The peak that appears at 1645 cm
-1
 is probably due to the presence of interstitial water in the 
cellulosic structure.
29
 
The spectrum of cotton fabric impregnated with limonene microcapsules (Figure 6.25.E) has 
shown the disappearance of the sharp peaks at 1742 cm
-1
 and 1693 cm
-1
 that previously appeared 
in the spectrum of the cross-linker citric acid, which indicates that they had become involved in 
bonding, i.e., the esterification reaction between the carboxylic group of citric acid and the –OH 
group of the cotton cellulose.
10
 The spectrum also revealed the appearance of a new peak of C=O 
ester stretching at 1729 cm
-1
, which was not present in the control cotton fabric sample. This 
peak confirms the covalent attachment between the polymeric shell of the microcapsules (of 
chitosan and gum Arabic) and cotton cellulose via citric acid through ester bond formation.
12
 
Additionally, the presence of a peak at 1637 cm
-1 
with small intensity, which is assigned to the 
bending vibration of the –NH group, points out to the chemical reaction between the residual free 
–NH2 groups of chitosan in the microcapsules shells and the –COOH groups of citric acid.
10
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Figure 6.25 FTIR spectra of: A) tannic acid; B) microcapsules; C) citric acid; D) untreated 
cotton fabric and E) cotton fabric treated with microcapsules. 
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6.3.3. Antibacterial activity 
6.3.3.1. Agar diffusion 
This assay was conducted to investigate the antibacterial activity of the free microcapsules 
before being grafted onto the fabrics. Figures 6.26 and 6.27 show the results of the agar diffusion 
assay for different formulations of limonene and vanillin, respectively. The results indicated that 
all the formulations exhibited bacterial growth inhibition against both S. aureus and E.coli. Table 
6.5 lists the values of the measured diameters of the inhibition zones of the formulations after 
incubating the plates for 24 hours and for 4 days, the assay was performed in duplicate for each 
sample. Since the antibacterial effect of chitosan mainly depends on the presence of its positively 
charged amino groups freely to interact with the negative charges of the bacterial wall,
30
 it is 
important to mention that the antibacterial effect exhibited by the microcapsules is 
predominantly due to the encapsulated vanillin and limonene during their release trough the 
microcapsules wall (chitosan and gum Arabic), and not from the chitosan itself. This is because 
during the microcapsules preparation process by the complex coacervation method most of the 
positively amino groups of chitosan have been complexed with negative carboxylic groups of the 
gum Arabic to form the shell of the microcapsules. 
The higher initial antibacterial effect that was exhibited by the non-encapsulated limonene oil 
dissolved in DMSO, and manifested in the bigger zone of inhibition (as shown in Table 6.5)  
might be related to the antibacterial activity of DMSO along with the limonene.
31
 Furthermore, it 
has been observed for the previously obtained inhibition zones, that after 4 days of incubation, 
they have become covered with bacteria. In contrast, the bacterial effect of the encapsulated oil 
was maintained after 4 days of incubation under the same conditions. This sustainable 
antibacterial effect of the encapsulated limonene and vanillin in the examined microcapsules 
formulations is acquired as a result of the achieved controlled release (previously investigated in 
chapter 5), and demonstrates the enhanced stability and prolonged antibacterial effect of the 
encapsulated core materials, which would extend the potential use of vanillin and limonene 
microcapsules in different applications. 
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Table 6.5 Average diameters of inhibition zones (cm) of limonene and vanillin microcapsules 
suspensions and free oils in the plate test with E. coli and S. aureus. 
Formulation/Sample 
E.coli S. aureus 
After 24 
hours of 
incubation 
 After 4 
days of 
incubation 
After 24 
hours of 
incubation 
After 4 days 
of 
incubation 
C
o
re
 m
at
er
ia
l L
im
o
n
en
e 
4 1.25±0.080 1.25±0.080 1.50±0.133 1.50±0.133 
5 1.5±0.000 1.5±0.000 1.45±0.069 1.45±0.069 
6 1.25±0.400 1.25±0.400 1.35±0.074 1.35±0.074 
V
an
il
li
n
 
7 1.45±0.207 1.45±0.207 1.45±0.069 1.45±0.069 
8 1.50±0.000 1.55±0.065 1.50±0.000 1.55±0.065 
9 0.80±0.000 1.20±000 1.55±0.065 1.55±0.065 
Limonene oil/DMSO 3.30±0.303 
- (*) 
 
3.30±0.181 
- (*) 
 
Vanillin /corn oil 0.95±0.316 
- (*) 
 
1.00±0.200 
- (*) 
 
- (*) After 4 days of incubation, the bacteria grown up in the inhibition zone initially formed. 
6.3.3.2. Standard test method under dynamic contact conditions 
This assay was conducted on cotton fabrics impregnated with limonene microcapsules of 
formulation 5 and vanillin microcapsules of formulation 8 (cured at 120º C for 3 minutes); as 
they gave good grafting outcome .The assay was performed after washing the samples by the 
method previously described in Section 6.2.4.4. The results of the assay for formulation 5 and 8 
are shown in Table 6.6 and Table 6.7, respectively. 
 
 137 
 
 
Figure 6.26 Zone of inhibitions of limonene microcapsules of formulations: a (4), b (5) and c (6) 
against S. aureus, and of formulations: d (4), e (5) and f (6) against E.coli after 24 hours of 
incubation. 
 
Figure 6.27 Zone of inhibitions of vanillin microcapsules of formulations: a (7), b (8) and c (9) 
against S. aureus, and of formulations: d (7), e (8) and f (9) against E.coli after 24 hours of 
incubation. 
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Table 6.6 Results of the bacterial reduction % in the dynamic test of the fabric impregnated with 
limonene microcapsules formulation 5. 
Time 
(minutes) 
Sample 
Bacterial 
reduction * 
(%) 
Number of 
bacteria – 
inoculum 
solution 
(CFU/ml) (A) 
Number of 
bacteria – control 
(fabric without 
microcapsules) 
 (CFU/ml) 
Number of 
bacteria – sample 
(fabric with 
limonene 
microcapsules) 
(CFU/ml) (B) 
0 3.00x10
5
 3.00x10
5
 1.50x10
4 
49.00 
15 3.00x10
5
 2.50x10
5
 1.24x10
4
 95.90 
30 3.00x10
5
 2.96x10
5
 1.42x10
4
 52.72 
45 3.00x10
5
 2.81x10
5
 1.69x10
4
 43.70 
60 3.00x10
5
 2.94x10
5
 1.91x10
4 
36.33 
75 2.98x10
5
 2.96x10
5
 1.91x10
4
 35.92 
90 2.90x10
5
 2.86x10
5
 1.93x10
4
 33.44 
105 3.00x10
5
 2.88x10
5
 2.20x10
4
 33.03 
120 3.00x10
5
 3.00x10
5
 2.20x10
4
 26.72 
       (*) – reduction of the bacteria number = (A-B)/A*100 
It can be observed, that both fabric samples exhibited an antibacterial activity against E. coli, 
whereby the fabric treated with limonene microcapsules showed 95.90% of bacterial reduction 
and the one impregnated with vanillin microcapsules showed 98.17 % after 15 minutes of 
contact. A bacteriostatic activity is generally regarded if a reduction percentage between 90% 
and 99.9% of the total bacteria count (CFU/mL) in the original inoculum is obtained.
22
 As was 
mentioned previously, this assay involved the renewal of the bacterial inoculum at each 
sampling. In other words, every 15 minutes the fabric sample was withdrawn, washed thoroughly 
with sterilized water and placed in contact with a new/fresh bacterial inoculum in order to take 
samples for colony counting. It is obvious from the results obtained that although the bacterial 
reduction percentage decreased with time, nevertheless, it was maintained throughout the 8 
renewal cycles for both fabric samples, which is consistent with a gradual release and a long 
lasting effect. 
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Table 6.7 Results of the bacterial reduction % in the dynamic test of the fabric impregnated with 
vanillin microcapsules of formulation 8. 
Time 
(minutes) 
Sample 
Bacterial 
reduction * 
(%) 
Number of 
bacteria – 
inoculum 
solution 
(CFU/ml) (A) 
Number of 
bacteria – control 
(fabric without 
microcapsules) 
 (CFU/ml) 
Number of 
bacteria – sample 
(fabric with 
vanillin 
microcapsules) 
(CFU/ml) (B) 
0 3.00x10
5
 2.94x10
5
 1.34x10
4 
55.30 
15 3.00x10
5
 2.74x10
5
 5.50x10
2
 98.17 
30 2.50x10
5
 2.69x10
5
 1.41x10
4
 43.60 
45 2.45x10
5
 2.93x10
5
 1.58x10
4
 35.51 
60 2.36x10
5
 2.95x10
5
 1.54x10
4 
34.80 
75 2.71x10
5
 2.94x10
5
 1.88x10
4
 30.63 
90 2.82x10
5
 2.92x10
5
 1.98x10
4
 29.80 
105 2.78x10
5
 2.94x10
5
 1.96x10
4
 29.50 
120 2.60x10
5
 2.96x10
5
 1.99x10
4
 23.46 
       (*) – reduction of the bacteria number = (A-B)/A*100 
6.4. Conclusion 
In this chapter, the possibility of imparting a durable antimicrobial finish to cotton fabrics by the 
impregnation of the limonene and vanillin microcapsules was successfully achieved using green 
and non-toxic materials. Nine formulations of microcapsules and several methods for their 
grafting onto the cotton fabrics were investigated. Considering the optimum fixation conditions, 
it was found that the use of citric acid as a polycarboxylic acid cross-linker followed by the 
thermofixation and thermal curing (at 120ºC) provided higher yield of attached microcapsules 
without affecting their morphology. 
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Appendix 6.  Particle size distribution charts of the formulations investigated in Chapter 
6   
 
(a) 
 
(b) 
Figure 6.A Particle size distribution of vanillin microcapsules of formulation 1; (a) distribution 
in volume (b) in number.  
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(a) 
 
(b) 
Figure 6.B Particle size distribution of vanillin microcapsules of formulation 2; (a) distribution 
in volume (b) in number.  
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(a)  
 
(b) 
Figure 6.C Particle size distribution of limonene microcapsules of formulation 5; (a) distribution 
in volume (b) in number.   
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(a) 
 
(b) 
Figure 6.D Particle size distribution of vanillin microcapsules of formulation 7; (a) distribution 
in volume (b) in number. 
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(a) 
 
(b) 
Figure 6.E Particle size distribution of vanillin microcapsules of formulation 9; (a) distribution 
in volume (b) in number. 
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Chapter 7: General Conclusions and Future Prospects  
In light of the proposed objectives and the obtained results of this thesis project, it could be 
concluded that the production of microcapsules with fragrant and antimicrobial properties and 
their application onto textile substrate using eco-friendly materials was successfully achieved.  
In summary, the main findings of the work are: 
- The production of limonene and vanillin microcapsules was accomplished by means of 
the complex coacervation using gum Arabic and chitosan as shell materials and green 
hardening agents (tannic acid and sodium TPP). To our knowledge, this is the first 
successful encapsulation of the cargo using this method; as the available literature on 
complex coacervation to date did not refer to the encapsulation of limonene and vanillin 
(in pure form and not vanilla oil) by the usage of chitosan and gum Arabic as the wall 
material pair. 
- The type of the emulsifier used in the microcapsule preparation was found to have a 
significant influence on their size, morphology (being mononuclear or polynuclear), EE% 
and the release pattern of the core material through the wall. 
- The encapsulation efficiencies of the prepared microcapsule formulations was determined 
by GC-FID and ranged between 62% and 100% and the values highly depended on the 
emulsifier used. Span 85 emulsifier resulted in the highest EE %. 
- The release profile was affected by the concentration of the used biopolymers, type of 
core material and the morphology of the microcapsules. Increasing the amount of 
polymeric wall materials resulted in slower release rate. Additionally, it was found that 
lower amount of vanillin than limonene was released over the same release duration and 
conditions. This might be related to the lower volatility and also diffusivity of the former. 
It was also noted that the limonene multinuclear microcapsules demonstrated slower 
release rate than the mononuclear ones. 
- Among all the different formulations that were prepared, it was confirmed by SEM and 
FTIR that the multinuclear limonene and vanillin microcapsules obtained by the PGPR 
emulsifier and hardened with tannic acid are the ones that tolerated the thermofixation 
conditions and were successfully grafted on the cotton fabrics by citric acid. This 
highlights the fact that some formulations, regardless of their high EE% and uniform 
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release profiles were not suitable for the grafting reaction and could not survive its high 
temperature. 
- The antibacterial assays of both the free microcapsules and the treated cotton fabrics have 
shown that they exhibited a sustained antibacterial activity. The average diameters of the 
inhibition zones of the agar diffusion tests ranged between 0.8-1.5 cm against E. coli, and 
1.35-1.55 cm against S. aureus, and did not show a significant increase after being 
incubated for 4 days. However, this inhibitory effect of the microcapsules was 
maintained, unlike the non-encapsulated limonene and vanillin, which displayed bacterial 
growth in the inhibition zones that were initially formed; indicating un-sustained bacterial 
inhibition. The cotton fabrics impregnated with limonene and vanillin microcapsules 
have shown 95.9 % and 98.2 % of bacterial reduction after 15 minutes of exposure, 
respectively. This percentage significantly decreased but the bacterial reduction was 
maintained to more than 20% after 8 renewable cycles of the bacterial inoculum. 
Suggestions for future research: 
- It is recommended that future work on the impregnated fabrics produced here would 
focus on the washing durability and maintaining the fragrant and the antimicrobial effect 
of the treated fabrics after several washing cycles. This would in turn promote the 
extension of the production to a large scale. 
- Another important area for future research is working on narrowing the size distribution 
of the produced microcapsules; as this is expected to affect the release behavior and 
uniformity of the grafted microcapsules. 
- It is also important in the next step to study the release of the active agents from the 
microcapsules after being fixed on the fabrics. This would help in determining whether 
the fixed microcapsules would maintain the same release profiles as the free ones or the 
grafting affects their release pattern. 
- More investigations are needed to be conducted on the formulations of vanillin and 
limonene microcapsules that were produced by Span 85 emulsifier and have shown the 
highest EE% (ranging between 98.6% and 100 %) but failed to be grafted on cotton 
fabrics by citric acid. These microcapsules exhibited a controlled release profile and 
sustained antibacterial activity against S. aureus and E. coli. Therefore, it is desirable to 
study their fixation on the fabrics by other means or their incorporation in other possible 
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applications, such as cosmetics or food products that do not need high processing 
temperature range. 
 
 
 
 
